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Patterns of molecular evolution and epistasis on a genomic and genic scale 
 
Abstract 
Epistasis describes non-additive interactions which affect gene expression and 
phenotype. It can happen on multiple levels, including on a genomic level with 
interactions between genes or even chromosomes affecting global patterns of gene 
expression. It can also happen within a gene itself, with epistatic interactions between 
amino acids affecting gene expression and resultant phenotypes. I present three studies in 
two organisms to study this phenomenon on a global-genomic scale, and also on a local-
genic scale. 
First, I present evidence that epistatic interactions between Y-linked regulatory 
polymorphisms and genetic background affect global gene expression in Drosophila 
melanogaster. The Y chromosome is a heterochromatic, degenerate chromosome and 
thought to have little evolutionary consequence. I studied Y chromosomes from two 
populations of D. melanogaster that are known to have major effects on the thermal 
tolerance of spermatogenesis. I show that these Y chromosomes differentially modify the 
expression of hundreds of autosomal and X-linked genes, but the effect depends on the 
genetic background the Y finds itself in. Second, I present novel evidence suggesting that 
the mechanism for Y-regulatory variation (YRV) is heterochromatin-based. Imprinting 
(due to parent-of-origin inheritance) in Drosophila has been documented mainly in 
heterochromatic regions, in particular the Y chromosome. I show that sex-specific 
transmission of the Y can lead to polymorphic imprinting and can change the magnitude 
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and scope of YRV, perhaps through differential titration of chromatin proteins. In 
particular, genes responding to this polymorphic imprint were more likely to be male-
specific, testis-specific, and involved in rDNA transcript levels. This is particularly 
intriguing as rDNA processing is known to be affected by heterochromatin formation. 
 Finally, I study how mutational interactions within one gene can constrain 
evolutionary trajectories. The human malaria parasite, Plasmodium vivax, varies at 
several positions in the gene dihydrofolate reductase (DHFR), reflecting the mark of 
selection for drug resistance. Variation at four amino acid sites allows us to reconstruct a 
complete fitness landscape using all possible combinations of mutational variants within 
the gene. The results suggest that sign epistasis, where one mutation does well on some 
backgrounds but poorly on others, is common within P. vivax DHFR. In addition, drug 
concentration and effective population size can have a strong effect on whether the most 
resistant, quadruple-mutant, allele will fix in a population. I propose this may explain 
why the most resistant allele is missing from common polymorphic natural isolates.  
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Y not a dead end: Epistatic interactions between Y-linked regulatory polymorphisms and 
genetic background affect global gene expression in Drosophila melanogaster 
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ABSTRACT 
The Y chromosome, inherited without meiotic recombination from father to son, 
carries relatively few genes in most species. This is consistent with predictions from 
evolutionary theory that nonrecombining chromosomes lack variation and degenerate 
rapidly. However, recent work has suggested a dynamic role for the Y chromosome in 
gene regulation, a finding with important implications for spermatogenesis and male 
fitness. We studied Y chromosomes from two populations of Drosophila melanogaster 
that had previously been shown to have major effects on the thermal tolerance of 
spermatogenesis. We show that these Y chromosomes differentially modify the 
expression of hundreds of autosomal and X-linked genes. Genes showing Y-linked 
regulatory variation (YRV) also show an association with immune response and 
pheromone detection. Indeed, genes located proximal to the euchromatin-
heterochromatin boundary of the X chromosome appear particularly responsive to Y-
linked variation, including a substantial number of odorant-binding genes. Furthermore, 
the data show significant regulatory interactions between the Y chromosome and the 
genetic background of autosomes and X chromosome. Altogether, our findings support 
the view that inter-population, Y-linked regulatory polymorphisms can differentially 
modulate the expression of many genes important to male fitness, and they also point to 
complex interactions between the Y chromosome and genetic background affecting global 
gene expression. 
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INTRODUCTION 
 The Y chromosome is transmitted without sexual recombination from father to son. 
In the Y chromosome, as in other nonrecombining regions, complete linkage between 
genes results in the accumulation of deleterious alleles and the loss of genetic diversity 
due to the evolutionary processes of Muller’s ratchet, background selection, and genetic 
hitchhiking (Bull, 1983; Rice, 1987, Charlesworth and Charlesworth, 2000; Bachtrog, et 
al. 2008). Consistent with theory, the Y chromosome of Drosophila melanogaster carries 
only thirteen known protein-coding genes (Carvalho et al 2001; Carvalho and Clark, 
2005; Koerich et al 2008; Vibranovski et al. 2008; Krsticevic et al, 2010), whereas over 
5,000 genes would be expected from typical gene densities in euchromatic regions.  
 Six of the thirteen genes discovered on the Y chromosome are male fertility factors 
that either encode structural components of spermatogenesis or regulate spermatogenesis-
specific processes such as individualization (Carvalho 2000; Carvalho et al 2009). 
Spermatogenesis in Drosophila males is extremely sensitive to heat, with males becoming 
sterile anywhere from 23°C in heat-sensitive species to 31°C in heat-tolerant species 
(Chakir et al 2002; David et al. 2005). In D. melanogaster, Rohmer et al. (2004) found 
that differences between Y-chromosome lineages from tropical and temperate regions are 
responsible for much of the variation in thermal sensitivity of spermatogenesis. Since 
spermatogenesis is essential for male fitness, we expect a Y-chromosome effect on 
thermal sensitivity to translate into effects on male fitness. However, Y-chromosome 
effects on fitness can occur even at constant temperatures: Chippindale and Rice (2001) 
showed that polymorphisms in the Y chromosome have a large effect on male fitness, 
with total genetic variance in fitness comprising a limited contribution of additive genetic 
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variance but a substantial contribution of epistatic genetic variance. Accordingly, the 
contribution of a Y chromosome to fitness was found to be highly dependent on the 
genetic background of autosomes and the X chromosome. 
 While Y-linked protein coding genes show effectively no nucleotide diversity 
(average pair-wise differences, π) within Drosophila melanogaster (Zurovcova and 
Eanes, 1999) and very low levels of diversity in human populations (Shen et al., 1997; 
Rozen et al., 2009), Y-linked heterochromatic and rDNA repeats in both flies and humans 
can differ in repeat number or length (Karafet et al., 1998; Lyckegaard and Clark, 1989; 
Lyckegaard and Clark, 1991; Repping et al., 2003). Moreover, recent studies showed that 
the Y chromosome has undergone rapid evolution and turnover of protein-coding genes 
between humans and chimpanzee (Hughes et al., 2010) as well as among species of 
Drosophila (Koerich et al., 2008) 
 While no Y-linked transcription factors have been found in Drosophila, the Y 
chromosome is known to be a pervasive modulator of gene activity elsewhere in the 
genome. One phenomenon in which the Y chromosome affects expression of genes is 
position effect variegation (PEV) (Muller, 1930; Gatti and Pimpinelli, 1992; Talbert and 
Henikoff, 2006; Schulze and Wallrath, 2007). PEV occurs when genes are relocated next 
to a heterochromatin-euchromatin boundary. While these genes remain unchanged at the 
DNA level, they are transcriptionally repressed in some cells but not others. A classic 
example is the repositioning of the w[m4] allele from its normal location in euchromatin 
near the tip of the X chromosome to a new location close to an AT-rich microsatellite 
region in the pericentromeric heterochromatin near the base of the X (Muller, 1930). The 
variegated expression of w[m4] results in a mosaic, red-white eye-color phenotype. PEV-
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associated repression of gene transcription is thought to result from the spread of 
pericentromeric heterochromatin into neighboring genes with consequent transcriptional 
silencing of those genes (Schulze and Wallrath, 2007). Y-chromosomal heterochromatin 
is known to suppress PEV in both XY males and XXY females (Dorer and Henikoff, 
1994), with the level of suppression proportional to the amount of the Y-chromosome 
heterochromatin present (Dimitri and Pisano, 1989). One model for these effects is the 
competitive sequestration of chromatin-associated proteins by Y-linked microsatellite 
repeats (Lloyd et al., 1997; Wallrath, 1998). 
 Recent work by Lemos et al. (2008) has shown that the modulating effect of cryptic 
Y-chromosome polymorphisms on gene expression is pervasive throughout the D. 
melanogaster genome. Accordingly, males differing only in the origin of their Y 
chromosome showed differential expression at hundreds of non-Y-linked genes. 
Interestingly, many of these genes have male-biased expression and seem to be involved 
in species divergence and temperature adaptation. These results provided a molecular 
framework for how the Y chromosome affects adaptive phenotypic variation and fitness 
(Voelker and Kojima, 1971; Chippindale and Rice, 2001; Rohmer et al., 2004).  
 The role of genetic background on Y-linked regulatory variation (YRV) remains to 
be addressed. Previous experiments by Lemos et al. (2008) placed Y chromosomes in the 
genetic background of an inbred, homogeneous laboratory strain (B4361). This 
laboratory strain was chosen to ensure uniformity of genetic background. However, 
autosomal and X-chromosome polymorphisms occurring in natural populations may lend 
themselves to subtle modifications by cryptic Y-linked regulatory polymorphisms. In 
accordance with this possibility, Chippindale and Rice (2001) found significant 
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background-by-Y interaction effects on male fitness. In addition, no studies have yet 
investigated the physical clustering of the genes affected by YRV along chromosomes.  
 This study is aimed at addressing the following questions: (i) Which genes show 
regulatory modulation due to Y-by-background effects? (ii) Which functional categories 
do these genes fall into?  (iii) Do the genes affected by YRV show distinctive physical 
clustering patterns along autosomes or X chromosome? (iv) Is PEV differentially 
modulated by specific Y-by-background combinations? The Y chromosomes chosen were 
sampled from a tropical (India) and temperate (France) population of D. melanogaster. 
Flies from these populations have previously been shown to have major differences in 
their ability to carry out spermatogenesis under heat stress, in large part due to 
polymorphic variation between their Y chromosomes (Rohmer et al. 2004). Here we test 
the effect of the Y chromosomes on gene expression not only in the genetic background 
of an inbred laboratory strain, but also in the genetic background of both the tropical and 
temperate populations from which the Y chromosomes were derived. This experimental 
design allowed us to address the extant to which the expression of polymorphic Y-linked 
variation depends on the subtleties of genomic background. A gene-density plotting 
algorithm was used to test for physical clustering of genes showing YRV. Finally, both 
naturally occurring Y chromosomes were assayed for polymorphisms capable of 
regulating PEV. 
 
MATERIALS AND METHODS 
Fly strains: 
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Wild flies were collected from Draveil, France (in 2001) and Delhi, India (in 
1997) by members of Jean R. David’s research group (Rohmer et al, 2004), and 
generously provided to us for analysis. For each population, wild-collected females were 
isolated in culture vials, and isofemale lines established. These lines (a minimum of 10) 
were eventually pooled to make a mass culture. Approximately 100 males per population 
were drawn from mass culture for crosses (Figure S1.1) which allowed Y chromosomes 
from the French population to be introgressed into an otherwise Indian autosomal and X-
chromosomal background, and vice versa.  Y chromosomes from both populations were 
also introgressed into the same laboratory genetic background (B4361) used by Lemos et 
al. (2008). Hence, six strains were used for analysis. These consisted of the original 
French and Indian lines with their native Y chromosomes, namely: French background 
with French Y chromosome (French : YF), and Indian background with Indian Y 
chromosome (Indian : YI). In addition we studied four Y-substituted strains, namely, 
Indian genetic background with French Y chromosome (Indian : YF), laboratory 
background with French Y chromosome (B4361 : YF), France background with Indian Y 
chromosome (French : YI), and laboratory background with Indian Y chromosome (B4361 
: YI). Males from these strains were collected for use in microarray dye-swap 
experiments. Newly emerged males were collected on the tenth day after egg laying and 
allowed to age for three days at 25°C, after which they were flash frozen in liquid 
nitrogen and stored at -80°C. 
 All crosses for each Y-substitution line were carried out with 10–15 vials with 
multiple mating pairs per vial. Gene expression differences between males were assayed 
in flies grown under carefully controlled environments - 24h light, 25°C, and constant 
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humidity - and harboring naturally occurring Y-chromosome variants. 
 
 
Microarray hybridizations and analysis: 
Our experimental design consisted of 16 cDNA microarrays, 4–6 for each of the 
three backgrounds (French, Indian, and B4361), involving 32 separate labeling reactions. 
We contrasted two Y chromosomes (YI and YF) on each microarray. Microarrays were 
~18,000-feature cDNA arrays spotted with D. melanogaster cDNA PCR products as 
described (Lemos et al., 2008). RNA extraction, cDNA synthesis, microarray 
hybridization, and microarray slide scanning protocols closely followed that of Lemos et 
al (2008). Foreground fluorescence of dye intensities was normalized by the Loess 
method implemented in the library Limma of the statistical software R. Microarray gene 
expression data herein reported can be obtained at the GEO database (GSE21587). 
Significance of variation in gene expression in each background due only to the Y 
chromosome was assessed using the Bayesian Analysis of Gene Expression Levels 
(BAGEL) algorithm (Townsend and Hartl, 2002). False discovery rates (FDR) were 
estimated empirically based on the variation observed when randomized versions of the 
original dataset were analyzed. Density along chromosomes of genes showing Y-linked 
regulatory variation as assessed by BAGEL was plotted using a sliding window algorithm 
with window size of 2 Mb, sliding in 1 Mb increments. Confidence intervals were 
estimated empirically by running the density-plotting algorithm on 1000 sets of randomly 
sampled genes taken from the genome as a whole as represented by features on the 
microarray, with gene number equal to the number of differentially expressed genes. 
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Cutoff 95% densities were plotted, and any clusters with observed densities beyond these 
values were regarded as significant. 
To test for the effect of Y-by-background interaction on gene expression, a linear 
model was fitted to normalized data: γij = µ + Bi + Yj + I(Background × Y)ij + eijk, where 
γij is the normalized-transformed gene expression, µ is the population mean, Bi is the 
effect of the ith genetic background, Yj is the effect of the jth Y chromosome, 
I(Background × Y)ij is the effect of background-by-Y interaction, and eijk is the residual 
effect. To test for agreement with the BAGEL results, a second model was implemented 
to test for Y-only effects: γij = µ + Yj + eijk  , where Yj refers to YI or YF. The significance 
of effects from Y-only and background-by-Y interactions were tested using the Fs-test, a 
modified F-statistic incorporating shrinkage variance components (Cui et al., 2005). P 
values were calculated by performing 1000 permutations of samples, and corrected for 
multiple hypotheses testing by the q-value false discovery rate method (Storey and 
Tibshirani, 2003). Significant changes were determined at the FDR threshold of 0.01. A 
k-means analysis was used to identify groups of genes with similar expression patterns 
across Y-by-background groups. In the bootstrapped k-means algorithm, a gene was 
assigned to a group if it was identified in 80% of 1,000 iterations. This was repeated for 
different values of k to find the k needed to minimize the number of genes not identified 
in any group. All analyses described in this paragraph were computed with the 
R/Maanova package (Wu et al., 2003) 
 Enrichment in gene ontology categories was assessed with GeneMerge (Castillo-
Davis and Hartl, 2003), which uses a hypergeometric distribution to assess significance. 
Because GeneMerge tests for all categories, a modified Bonferonni correction was used 
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to account for multiple testing. 
 
Position effect variegation (PEV): 
Males from all four populations were crossed to females from a stock carrying 
w[m4h] (Figure S2). These females possess an inversion on the X chromosome that 
repositions the w[m4h] gene proximal to the X-centromere. All flies were maintained at 
either 25°C or 18°C. Males from these crosses were collected, flash frozen in liquid 
nitrogen, aged for 3 days at either 25°C or 18°C, and stored at -80°C. Heads of males 
were removed with a blade, and homogenized 5 to a tube with 10uL of acidified ethanol 
(30% ethanol acidified to pH 2 with HCl). Eye pigment expression was assessed with 
spectrophotometric analysis at an optical density of 480 nm. 4–6 biological replicates 
were used per treatment, with two measurements taken per replicate. The correlation 
between repeat measures was high (Pearson’s r = 0.90), thus their means were used in 
subsequent analyses. Males displaying typical eye-pigmentation phenotypes were imaged 
using an auto-montage system (Snycroscopy, Frederick, MD). A 3-way ANOVA 
analysis, using statistical software JMP, was performed using male background (Indian, 
French, or B4361), Y chromosome (YI or YF), and temperature (25°C or 18°C) as factors.  
 
RESULTS 
Global gene expression variation: 
Males differing only in their Y chromosomes (either YI or YF) showed differential 
expression of a substantial number of genes, with the exact number depending on the 
genetic background interrogated and the cutoff for significance used (12 to 1178 genes 
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when the Bayesian posterior probability is > 0.999 or 0.90, corresponding to false 
discovery rates [FDR] of < 1% or 35%, respectively; Figure 1.1]. For every genetic 
background, and at every significance cutoff value, the observed number of genes 
differentially expressed among YI and YF males exceeded the number expected by chance. 
Overlap of differentially expressed genes sets between the three different backgrounds is 
shown in Figure 1.2. The results suggest that although Y-linked regulatory 
polymorphisms have different modulating effects on genes depending on the genetic 
background of the male, there is some agreement on the genes showing Y-linked 
regulatory variation (YRV). All the following analyses are based on genes affected by 
YRV identified with a criterion of a Bayesian posterior probability > 0.95.  
Clustering of genes showing YRV into significant functional categories is listed 
in Table 1.1. Of note, pheromone binding and immune response genes are heavily 
represented, as well as genes localized to extracellular regions across all three 
backgrounds. This again suggests that genes showing YRV show a consistent pattern 
with respect to function. 
Physical clustering of genes along chromosomes was also examined. While no 
physical clustering is apparent in the autosomes, males possessing YF showed 
overexpression of genes near the euchromatin-heterochromatin boundary of the X 
chromosome (at chromosome position 22 Mb) as compared to males possessing YI 
(Figure 1.3). This pattern holds true in both the Indian and French genetic backgrounds, 
but not in the B4361 genetic background. In the Indian background, 5 genes near the X-
chromosome euchromatin-heterochromatin boundary showed this pattern of 
overexpression in YF males compared to YI. Of these, one encodes a protein categorized  
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Figure 1.1 – Black bars represent the number of genes differentially expressed by males 
possessing YI or YF in an Indian genetic background (top panel), French genetic 
background (middle panel) or B4361 genetic background (lower panel), as a function of 
the Bayesian posterior probability of differential expression. Gray bars indicate the 
estimated number of genes expected by chance.  
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Figure 1.2 – Venn diagrams showing number of unique Y-regulated genes (Bayesian 
posterior probability  > 0.95) in Indian (I), French (F), and B4361 genetic backgrounds, 
and overlap between affected genes in different backgrounds. Number of genes found to 
be significant in each individual background is given in parentheses. 
F (273) B4361 (470) 
I (717) 
9 
123 
15 
27 
323 
558 
222 
 14 
Table 1.1 –  Significantly over-represented Gene Ontology categories for genes identified 
to be overexpressed in BAGEL analysis. P-values are adjusted for multiple hypothesis 
testing. 
  Background 
  I F B4361 
GO category Description Number of Genes 
Molecular Function    
GO:0004252 serine-type endopeptidase activity 14* 4 3 
GO:0005550 pheromone binding 5 6*** 1 
GO:0008145 phenylalkylamine binding 2 3* 1 
GO:0004364 glutathione transferase activity 10 7* 1 
Biological Processes 
GO:0006952 defense response 47*** 21* 17 
GO:0009636 response to toxin 19** 11** 4 
GO:0006508 proteolysis 62*** 18 24 
GO:0006961 antibacterial humoral response 5 6* 7 
GO:0019236 response to pheromone 2 4* 2 
Cellular Component 
GO:0005576 extracellular region 34*** 19*** 25* 
* P < 0.05 
** P < 0.01 
*** P < 0.001 
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Figure 1.3 –  Clustering of genes showing YRV along the euchromatic portion of the X 
chromosome in an Indian genetic background (top panel), French genetic background 
(middle panel) or B4361 genetic background (lower panel). Black lines indicate observed 
density of genes around a 2 Mb sliding window (step size 1 Mb). Grey lines indicate 95% 
confidence intervals. A schematic X chromosome is drawn in the top left panel with light 
areas representing euchromatin and dark areas representing heterochromatin. The dark 
knob at the right represents the X chromosome centromere. Columns represent genes for 
which males possessing YF showed enhanced expression over males possessing YI (YF > 
YI) or vice versa (YI > YF). An asterisk denotes a chromosomal segment containing 
significantly more genes showing Y-linked regulation than expected by chance. 
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Figure 1.3 (Continued)
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as sensory perception of chemical stimulus, namely gene Obp19a encoding odorant-
binding protein 19a. In the French genetic background, 3 genes near the X-chromosome 
euchromatin-heterochromatin boundary showed this pattern. All three encode proteins 
involved in the sensory perception of chemical stimulus (Obp19a and Obp19b encoding 
odorant-binding proteins 19a and 19b, and Pbprp3 encoding pheromone-binding protein-
related protein 3). The observed effect of the Y chromosome on modulating genes 
associated with pheromone binding and sensory perception has important implications for 
male fitness and sexual selection.  
The relative expression levels of three representative genes showing YRV are 
plotted in Figure 1.4. One gene, Obp19b, was chosen because it is located near the X-
chromosome euchromatin-heterochromatin boundary and was also identified in both the 
French and Indian backgrounds as being significantly overexpressed in YF compared to YI 
males. Two other genes, Dro (Drosocin) and Pbprp3 (pheromone-binding protein-related 
protein 3) were chosen because they belonged to biological clusters identified to be over-
represented in the YRV-regulated gene sets (immune response and pheromone binding, 
respectively). Ratios represent relative expression levels of genes in YF males over YI 
males in the three genetic backgrounds. The results show, again, how epistatic 
interactions between Y-linked polymorphisms and background can modulate the 
expression of non-Y-linked genes. Particularly striking is the differential relative 
expression of Dro, an immune response gene, in the three backgrounds: when comparing 
expression of Dro in YF males to YI males, it is underexpressed in the Indian background,  
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Figure 1.4 –  Relative expression levels of three genes showing YRV in YF males versus 
YI males in three genetic backgrounds (I, Indian; F, French; B4361). Expression levels are 
shown as the ratio of YF over YI expression (+ SE). Obp19a is an odorant binding-protein 
gene near the X euchromatin-heterochromatin boundary. Drosocin (Dro) is an immune-
response gene. Pbprp3 encodes pheromone-binding protein-related protein 3, a 
pheromone-binding protein.  
 19 
 
overexpressed in the French background, and slightly underexpressed in the B4361 
background.  
 
Extensive Y-by-background interaction: 
Y–by-background effects, as assessed by the Maanova linear model, influenced 
the expression of 346 genes (FDR < 0.01). Agreement between these results and the 
BAGEL results is strong: 252 (74%) of the 346 genes were also identified by BAGEL as 
differentially regulated by Y-linked polymorphisms in at least one of the genetic 
backgrounds (4361, Indian, or French) (Table S1.1). 200 (57.8%) of the 346 genes can be 
grouped most parsimoniously into three clusters of gene expression (Figure 1.5). In each 
cluster, genes show similar patterns of high expression in some Y-background 
combinations and low expression in others. Significant Gene Ontology categories within 
each cluster are listed in Table 1.2. In both methods of analysis (BAGEL and Maanova), 
immune response genes are heavily represented within significantly differentially 
expressed genes.  
Y-chromosome main effects, as identified by Maanova, regulate the differential 
expression of 192 genes. A proper comparison with BAGEL results called for re-analysis 
of global gene expression patterns across all arrays (regardless of genetic background) 
using BAGEL. When this was done, 484 genes showed differential gene expression 
(Bayesian Posterior Probability > 0.95). Of the 192 genes identified by Maanova, 106 
(55%) of them were also identified in the BAGEL gene set, while 86 (45%) were not. 
The 86 novel targets of YRV are not surprising in view of our results indicating strong  
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Figure 1.5 – Gene expression profiles generated by k-means clustering. Each line 
represents the expression of one gene across each background-by-Y group. Expression 
measures were standardized across groups, and analyzed using k-means cluster analysis. 
There are 19, 88, and 93 genes in clusters 1, 2, and 3, respectively. 
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Table 1.2 – Significantly over-represented functional Gene Ontology categories for gene 
expression clusters as identified by Maanova for Y-by-background effects. P-values are 
adjusted for multiple hypothesis testing.  
 
Cluster GO category Description 
 
Number of genes 
1 GO:0006961 antibacterial humoral response (sensu Protostomia) 
 
6*** 
1 GO:0042742 
 
defense response to bacterium 
 
4*** 
1 GO:0050829 
 
defense response to Gram-negative bacterium 
 
3*** 
1 GO:0050830 
 
defense response to Gram-positive bacterium 
 
2** 
1 GO:0001501 
 
skeletal development 
 
2** 
1 GO:0005975 
 
carbohydrate metabolic process 
 
3* 
2 GO:0019236 
 
response to pheromone 
 
3** 
2 GO:0045861 
 
negative regulation of proteolysis 
 
2* 
3 GO:0009405 
 
pathogenesis 
 
2* 
3 GO:0006631 
 
fatty acid metabolic process 
 
4* 
* P < 0.05 
** P < 0.01 
*** P < 0.001 
 
 
epistatic Y-by-background effects on gene expression. Such genes can fail to be identified 
by BAGEL because genes that are highly modulated by the Y chromosome in one genetic 
background but less so in others might show no consistent difference in expression 
between the temperate and tropical Y chromosomes when averaged across all genetic 
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backgrounds. 
 
Polymorphic Y chromosome effects on position effect variegation: 
The above results from microarray data suggesting large Y-by-background interaction 
effects on gene expression, as well as clustering of these effects near the X-chromosome 
euchromatin-heterochromatin boundary, were confirmed with a PEV assay. Males in the 
assay possessed either a YI or YF in a hybrid genetic background consisting of white-eye 
mutation w[m4h] positioned near the X chromosome euchromatin-heterochromatin 
boundary, a haploid autosomal genome sampled from the original stock containing the 
PEV marker, and a haploid autosomal genome sampled from the Indian, French, or 
B4361 laboratory populations. The results suggest that temperature does not affect 
suppression of PEV (P = 0.26). This result is surprising, as previous studies have shown 
that high temperatures during development suppress PEV, while low temperatures 
enhance PEV (Spofford, 1976; Zhang and Stankiewicz, 1998). There were also no 
significant temperature-interaction factors (temperature × Y chromosome, P = 0.92; 
temperature × genetic background, P = 0.41; temperature × background × Y chromosome, 
P = 0.73). On the other hand, YI and YF differed dramatically in their effects on position 
effect variegation (Figure 1.6, P < 0.0001), with YI males showing broader expression of 
w[m4h] than YF in all genetic backgrounds; however the effect is least pronounced in the  
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FIGURE 1.6. – Y-chromosome effects on position effect variegation (PEV). YI suppresses 
PEV more, and thus allows more expression of w[m4h], than YF in all three genetic 
backgrounds (I, Indian; F, French; B4361). Eye pigmentation was measured as absorption 
of light at 480 nm. Pictures of heads of representative male flies are shown to the right. 
 
 
B4361 background. Also importantly, genetic background showed a significant effect on 
PEV (P < 0.0001), with a similarly significant effect for Y-by-background interaction (P 
< 0.001). These results suggest that the modulation of PEV, which is caused by the 
mosaic expression of w[m4h], a gene positioned near the X chromosome euchromatin-
heterochromatin boundary, is sensitive to epistatic interactions between the Y 
chromosome and genetic background.  These results are therefore in agreement with the 
findings from our genome-wide gene expression assay.  
 
DISCUSSION 
The data presented here suggest that polymorphic variation in Y chromosomes 
from two geographically diverse D. melanogaster populations differentially regulate the 
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expression of hundreds of autosomal and X-linked genes. However, the contribution of Y 
chromosomes to global expression profiles depends on the genetic background of the 
bearer. Accordingly, we observed that the contribution of a temperate or a tropical Y 
chromosome to global gene expression is most pronounced when males differing only in 
the origin of their Y-chromosomes are assayed in their wild-type naturally occurring 
genetic backgrounds: Y-chromosome substitution lines in the Indian background showed 
more than twice the number of differentially expressed genes than Y-chromosome 
substitution lines in the French background.. This study also presents new data suggesting 
the physical clustering of genes exhibiting Y-linked regulatory variation (YRV). We 
found significant physical and functional clustering around the euchromatin-
heterochromatin boundary of the X chromosome, with X-linked olfaction-related genes 
showing higher transcription levels in males with YF than in males with YI. Finally, the Y-
by-background interaction effects on autosomal and X-linked gene expression, as well as 
the existence of polymorphic variation between the two Y chromosomes in their effects 
on modulating genes proximal to the euchromatin-heterochromatin boundary in the X-
chromosome, were confirmed with a position-effect variegation assay. 
Y-linked genetic variation has been previously documented for sex ratio (Carvalho 
et al., 1997; Montchamp-Moreau et al., 2001), male courtship (Huttunen and Aspi, 2003); 
geotaxis (Stoltenberg and Hirsch, 1997), thermal sensitivity of spermatogenesis (Rohmer 
et al., 2004), and fitness (Chippindale and Rice, 2001). For many of these traits (male 
courtship, geotaxis, spermatogenesis, and fitness), significant Y-by-background 
interaction effects have also been detected. Thus, our observations regarding substantial 
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Y-by-background interaction for gene expression traits are in good agreement with these 
previous findings regarding higher-level phenotypes. 
These findings of Y-chromosome effects on male phenotypes contrast with 
molecular analyses showing no polymorphism among 11 alleles of a 1738-bp region of a 
Y-linked gene in D. melanogaster (Zurovcova and Eanes, 1999).  In humans, Y-linked 
genes also show decreased levels of molecular variation, with a large-scale analysis of 
four Y-linked genes finding that coding regions show between 0% and 20% of the 
polymorphism of a sample of autosomal genes (Shen et al., 1997; Rozen et al., 2009). 
Despite the lack of nucleotide diversity in coding sequences of Y-linked genes, 
considerable structural polymorphism has been detected in the copy numbers of Y-linked 
heterochromatin repeats in humans and flies (Karafet et al., 1998; Lyckegaard and Clark, 
1989; Lyckegaard and Clark, 1991; Repping et al., 2003). Repeat sites have been shown 
to act as nucleation sites for heterochromatin formation via the RNAi pathway (Dorer and 
Henikoff, 1994; Elgin and Grewal, 2003; Volpe et al., 2002; Pal-Bhadra et al., 2004).  
Heterochromatin can influence transcription epigenetically, with the effect most 
easily observed in the modification of PEV by the Y chromosome (Dimitri and Pisano, 
1989; Dorer and Henikoff 1994). Large heterochromatic blocks, such as the Y 
chromosome, are thought to sequester limiting heterochromatin factors from other 
regions, thus impeding the spread of heterochromatin to nearby loci (Lloyd et al., 1996; 
Schulze and Wallrath, 2007). In this way, silencing of genes located near 
heterochromatin-euchromatin boundaries is suppressed. Balanced polymorphisms in Y-
chromosome heterochromatin repeats may provide the necessary molecular variation for 
differential competitive binding ability of chromatin proteins. The concomitant 
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redistribution of chromatin proteins will most strongly influence the expression of genes 
located next to other heterochromatic blocks, such as at euchromatin-heterochromatin 
boundaries. An alternate explanation for the influence of the Y chromosome on PEV is 
via the Y chromosome’s effect on RNA-interference pathways. The spread of 
heterochromatin is initiated through the transcription of repeat-DNA, and then 
propagated via the RNA-interference pathway. Lemos et al. (2008) found Y-linked 
polymorphisms responsible for the differential expression of transposable elements, 
which are known to undergo RNAi-mediated silencing. Therefore, mechanistic 
similarities underlying Y-linked effects on gene expression and PEV may exist. 
The acrocentric X chromosome of D. melanogaster is partitioned into 22 Mb of 
distal euchromatin, and 20 Mb of proximal heterochromatin (Adams et al 2000). As our 
results suggest, many of the genes showing Y-linked regulatory variation near the 
euchromatin-heterochromatin boundary in the X-chromosome are odorant-binding 
proteins, which are components of the insect olfactory system (Wang et al., 2009). 
Odorant receptors are rapidly evolving molecules in the Drosophila proteome (Robertson 
et al. 2003) and show altered expression following mating (McGraw et al. 2004). 
Interestingly, the genes affected by Y-linked regulatory elements exhibit significant 
functional coherence in showing association with pheromone detection. The influence of 
the Y chromosome on pheromone detection as well as odorant-binding proteins suggests a 
role for the Y chromosome in mating behavior and may help to explain the cessation of 
rigorous courtship and the reduced mating success of XO Drosophila males (Cordts and 
Partridge, 1996; Kuijper et al., 2006). In Anopheles mosquitoes, the Y chromosome has 
also been implicated in influencing mating behavior (Fraccaro et al., 1977). Because 
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many mating-behavior related proteins are selected for in different ways in males and 
females, there may be selection for sex-limitation of modifiers of their expression. Since 
the Y chromosome is male-limited, it serves as the perfect platform for these modifiers. 
Lemos et al. (2008) showed that genes showing Y-linked regulatory variation are more 
highly expressed in males than females, suggesting that the recruitment of modifiers of 
male-biased genes may have shaped the evolution of the Y chromosome. 
In addition to pheromone binding proteins, genes showing Y-linked regulatory 
variation are also associated with immune response and are more likely to be localized to 
the extracellular matrix than expected by chance. Although there are no previous studies 
of Y chromosome effects on immune response genes in Drosophila, studies in mice have 
found that Y-linked polymorphisms are capable of modifying autoimmune disease 
susceptibility (Teuscher et al., 2006; Spach et al., 2009). However, in mice, several genes 
of immunologic significance are located on the Y and may serve as candidates for 
explaining the effect. In Drosophila, no Y-linked immune-related genes are known. 
Therefore we suggest that our findings of Drosophila immune response genes being 
responsive to YRV are most likely explained by variation in non-coding components of 
the Y chromosome, such as repeat copy number. D. melanogaster populations from 
France and India are known to differ in the thermal sensitivity of spermatogenesis 
(Rohmer et al. 2004, David et al. 2005), with temperate and tropical Y-chromosomes 
contributing substantially to this difference. Among genes that show YRV in at least two 
of the three backgrounds, we find candidates known to be structural constituents of 
cytoskeleton (nod, CG9279, and tm2) and lipid metabolism (CG9914, CG17292, 
CG9458, CG11426, CG6295, CG6277, CG18815, CG31872). In addition, fatty acid 
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metabolism genes are overrepresented in one of the clusters detected by k-means analysis 
using Maanova. This suggests that, while the heat sensitivity of spermatogenesis express 
itself sharply at higher temperatures, the modulating effects of the Y chromosome on 
sperm-related traits may be subtle at permissive or less stressful temperatures. Lastly, 
localization of genes showing YRV to extracellular regions is expected, as many 
pheromone-binding proteins and proteins involved in immune response are receptor 
proteins with large extracellular domains. 
In summary, our finding of cryptic Y-linked regulatory control of hundreds of 
genes across various genetic backgrounds suggests standing Y-linked balanced 
polymorphisms in natural populations. At a cursory glance, this result seems incongruent 
with previous theoretical and empirical work suggesting little Y-linked polymorphism can 
be supported in a nonrecombining chromosome. However, our findings, together with 
other studies of the nontransitivity of sperm competition and Y-by-background 
interactions for male fitness (Clark et al., 2000; Chippindale and Rice, 2001), bring to 
light some complex and previously underappreciated dynamics for maintaining Y-linked 
polymorphisms. 
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ABSTRACT 
 
Our study describes a novel report of Y chromosome parent-of-origin imprint effects on 
global gene expression in Drosophila melanogaster. This supports past empirical work 
indicating that imprinting effects in this species are limited to heterochromatic regions of 
the genome, in particular, on the Y chromosome, which constitutes a large 
heterochromatic body. First, we show that maternal imprinting of the Y chromosome 
reduces the extent of Y-linked regulatory polymorphism. Second, rDNA transcription 
levels are correlated with a heterochromatin-related phenotype (position effect 
variegation). And third, there is a polymorphic imprint effect such that we can detect a 
significant Y-by-parent interaction effect when comparing two different Y chromosomes 
inherited either maternally or paternally. The genes showing this interaction effect are 
associated with essential male functions including spermatogenesis and specific 
expression in testes. This, together with previous research suggesting that imprinting is 
linked to changes in chromatin states, supports the hypothesis that the Y chromosome is 
acting as an important determinant of global gene expression diversity in males via 
chromatin remodeling mechanisms. We believe that naturally occurring Y chromosomes 
are polymorphic for elements that can regulate the expression of biologically relevant 
phenotypes by modulating a process that is changed by parent-of-origin imprinting, 
namely, the manipulation of global chromatin dynamics. 
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INTRODUCTION 
The Y chromosome is a genetic material found only in males and represents a 
unique genomic opportunity for the accumulation of genes benefiting males and the 
resolution of genetic conflicts (Rice et al. 2008). However, theoretical expectations of a 
broad role for the Y have not been matched by empirical findings due to the unusual 
molecular characteristics of this chromosome (with a few notable exceptions (Carvalho et 
al. 1997; Rice 1998; Chippindale and Rice 2001)). Because the Y chromosome is 
transmitted without recombination from father to son, complete linkage between genes 
results in the accumulation of deleterious alleles and the loss of genetic diversity (Bull 
1985; Rice 1987; Charlesworth and Charlesworth 2000; Bachtrog et al. 2008). In 
Drosophila melanogaster, the Y chromosome accounts for ~40 Mb of DNA (>20% of the 
haploid genome) (Carvalho 2002; Carvalho et al. 2009), but of the approximately 14,000 
genes in the D. melanogaster genome, only 13 (~0.1%) have been mapped to the Y, some 
of them encoding proteins for spermatogenesis-specific processes and others with 
functions yet unknown (Carvalho et al. 2009; Krsticevic et al. 2010). Within these few Y-
linked protein-coding genes, nucleotide diversity is effectively zero (Zurovcova and 
Eanes 1999), leading to the widespread belief that Y-linked genes are monomorphic 
within the species. This pattern of low gene density and nucleotide diversity on the Y 
holds in most animal species, including humans, where the Y chromosome harbors very 
few protein-coding genes in the male-specific region of the Y, and these genes also have 
very low polymorphism (Shen et al. 2000; Rozen et al. 2009).  
Despite the lack of sequence polymorphism in Y-linked genes, many Y-linked 
phenotypic traits in Drosophila have been observed. They include thermal sensitivity of 
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spermatogenesis (Chakir et al. 2002; David et al. 2005), male fitness (Chippindale and 
Rice 2001), reproductive isolation (Bayes and Malik 2009), sex ratio distortion (Carvalho 
et al. 1997; Montchamp-Moreau et al. 2001), sexually antagonistic zygotic drive (Rice et 
al. 2008), heterochromatic silencing (Dimitri and Pisano 1989; Dorer and Henikoff 
1994), genetic imprinting (Maggert and Golic 2002; Menon and Meller 2009), and 
courtship behavior (Huttunen and Aspi 2003). In addition, Y-linked interpopulation 
polymorphisms influence the expression of many genes located on other chromosomes, 
many of which are connected to male fitness (Sackton et al. 2011; Lemos et al.). In light 
of this seeming abundance of phenotypic variation associated with Y-polymorphism, the 
lack of nucleotide diversity in Y-linked genes seems incongruous. However, looking at 
structural variation on the Y, instead of sequence variation, may reconcile this 
conundrum. 
Structurally, the Y chromosome is unique because it is predominantly 
heterochromatic and highly enriched in repetitive sequences (Weiler and Wakimoto 
1995). Heterochromatin constitutes 20-30% of human and fly genomes (Smith 2007), and 
up to 85% of other genomes (Moritz and Roth 1976), but heterochromatin is still 
relatively poorly understood. The classic understanding of heterochromatin as 
transcriptionally repressive and inert is overly simplistic, as genes that natively reside 
within euchromatin can be silenced when transposed to heterochromatin, and vice versa 
(Hearn et al. 1991). Unlike the lack of diversity found in Y-linked, protein-coding genes, 
Y chromosome structural differences are pronounced: heterochromatic and rDNA repeats 
in Drosophila can differ in repeat number or length between different Y lineages 
(Lyckegaard and Clark 1989). Manipulating the amount of Y-linked heterochromatin can 
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affect heterochromatin-related phenotypes elsewhere. The most commonly studied 
heterochromatin-associated phenotype is position effect variegation (PEV), in which a 
classic example is the white-eye gene being repositioned from its native position in 
euchromatin near the tip of the X chromosome to a new position close to the AT-rich 
microsatellite region in the pericentromeric heterochromatin of the X (Muller 1930). This 
repositioning subjects the white-eye gene to the effects of heterochromatin spreading, and 
results in an eye color phenotype that is a mosaic of red and white.  Manipulations that 
increase the amount of Y-linked heterochromatin lead to decreased 
heterochromatinization near the euchromatin-heterochromatin boundary where the white-
eye gene is repositioned (Dimitri and Pisano 1989), which suggests the redistributional 
effect of a fairly constant supply of chromatin regulators. This observation also supports 
the locking-molecule model proposed by Zuckerkandle (Zuckerkandl 1974) that certain 
chromatin molecules are present in limited amounts, and act via repetitive sequences to 
cause transitions from euchromatic to heterochromatic states. This model was proposed 
in opposition to the simplistic view of chromosomes as being deterministically divided 
into two defined states. In further support of the idea that Y-heterochromatin is involved 
in Y-linked phenotypic variation, polymorphic Y’s sampled from geographically diverse 
D. melanogaster populations have differential effects on PEV (Lemos et al. 2008; Zhou 
et al. 2012) and enriched effects on genes located near the X chromosome euchromatin-
heterochromatin boundary (Jiang et al. 2010). 
Heterochromatin formation also affects rDNA arrays (Peng and Karpen 2007), 
with partial deletions of rDNA arrays resulting in reduced heterochromatin-induced gene 
silencing (Paredes and Maggert 2009). Overall heterochromatin levels in a cell are 
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difficult to quantify, however, the link between rDNA arrays and heterochromatin may 
provide an estimate: a recent study found that rRNA transcription indicates reduced 
heterochromatin in the genome (Larson et al. 2012). Taken together, these results suggest 
that polymorphisms in rDNA copy number might be relevant to global chromatin 
structure and concomitant gene regulation, and explains findings that Y-linked rDNA 
variation is an important determinant of global gene expression diversity in D. 
melanogaster (Paredes et al. 2011). 
Both males and female fruit flies can establish and maintain epigenetic chromatin 
states, and cases are known in other insects where males and females establish different 
epigenetic states in meiosis, termed imprints, resulting in parent-of-origin-dependent 
chromatin behavior. Imprinting in Drosophila has been mainly detected through 
modulation of PEV (Golic et al. 1998; Haller and Woodruff 2000; Maggert and Golic 
2002; Menon and Meller 2009). Heterochromatin formation is required for maintenance 
of imprint marks in zygotes and plays a central role in imprinting (Lloyd 2000). Because 
the Y chromosome constitutes a large heterochromatic body full of repetitive sequences, 
it has been proposed to act as a sink for chromatin modulators and other DNA-binding 
proteins which use repeat sequences as binding motifs, such as the GAGA transcription 
factor (Weiler and Wakimoto 1995; Lemos et al. 2008), which may effect establishment 
of chromatin states.  
Sex chromosomes are often studied for imprints because their inheritance is 
predictable. In female marsupials and in the placental tissues of female rodents, where 
dosage is compensated by X-inactivation in females, the paternal X is preferentially 
inactivated during dosage compensation (Migeon 1998). In Drosophila, this type of 
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specific inactivation is not expected since both X chromosomes are expressed in females, 
and dosage is compensated in males by overexpression of the X. In this genus, imprinting 
does not identify the X chromosome, as males are able to dosage compensate normally 
regardless of the origin of their X chromosome (Menon and Meller 2009). Few examples 
of autosomal imprints have been found, as experiments with deletions throughout the 
genome found uniparental diploids of D. melanogaster to be viable and to have no visible 
phenotype (Lindsley and Grell 1969). However, the Y chromosome presents a different 
story, as evidence from marker gene and PEV studies seem to suggest that the D. 
melanogaster Y is under imprint-regulated control, unlike the X or autosomes (Golic et al. 
1998; Haller and Woodruff 2000; Maggert and Golic 2002). Reversal of sex chromosome 
inheritance can reveal imprinting effects and has helped clarify the role of the Y in dosage 
compensation, where it likely modulates X chromosome recognition or the ability of the 
male-specific lethal complex to modify chromatin (Menon and Meller 2009). Previous 
work on imprinting in Drosophila has identified the imprint to reside only within 
heterochromatic, gene-poor regions, and thus, “while imprinting occurs in Drosophila, it 
is generally without phenotypic consequence” (Lloyd 2000). However, in light of our 
new understanding of the important role of the Y chromosome in regulating non-Y gene 
expression, and its potential to facilitate male-specific evolution, the imprinting of large 
heterochromatic bodies may have significant evolutionary consequences. We 
hypothesized that reversal of sex chromosome inheritance, if it disrupts the normal Y 
chromosome imprinting, may also lead to differential Y-linked regulatory variation 
between polymorphic Y’s. 
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In accordance with our hypothesis, we observed that reversed sex chromosome 
inheritance can dramatically alter the scope and magnitude of Y-linked regulatory 
variation in D. melanogaster. In agreement with previous findings, males carrying a Y 
chromosome derived from a population collected in the Democratic Republic of the 
Congo, Africa (Ycon) or a Y chromosome from a laboratory population collected in Ohio, 
USA (Ycs) showed differential expression, as determined by microarray analysis, at 
hundreds of autosomal and X-linked loci. We then exploited the fact that in diploid 
Drosophila, sex is determined not by the Y, but by the number of X chromosomes present 
(Baker and Belote 1983), and males can inherit their Y’s from XXY mothers (carrying an 
attached-X and a Y chromosome), and an X from normal XY males. These males also 
carried either Ycon or Ycs, but experienced reversed sex chromosome inheritance. 
Differential gene expression between these males was much reduced. Most interestingly, 
we found a set of hundreds of genes showing differential Y-by-origin interaction effects, 
with enrichment in this set for genes related to ribosomal function and male-specific 
traits. In addition, the effect of Y-by-origin interaction effects on PEV and rDNA 
transcription levels, two traits with demonstrated links to heterochromatin, were strongly 
correlated and consistent. We propose that parent-of-origin imprints established on the Y 
likely influenced the establishment of chromatin states on the chromosome, and altered 
the titration of available chromatin proteins within the nucleus, thereby influencing gene 
expression at multiple other loci whose expression is regulated, at least partially, at the 
structural, chromatin level.  
 
METHODS AND MATERIALS 
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Drosophila stocks. Two strains of diverse origin were used as donors of the Y-
chromosome: the common laboratory strain Canton-S (collected in Ohio in the 1940’s) 
and Tucson Drosophila Stock Center strain number 14021 (collected in the Democratic 
Republic of the Congo). Males from these strains were used for their Y chromosomes to 
be introgressed into the same laboratory stock background (BL4361, previously 
described) (Lemos et al. 2008; Jiang et al. 2010; Lemos et al. 2010). These crosses 
resulted in two isogenic cultures from which we could sample the Y chromosome, either 
Ycs or Ycon. Since Y chromosomes in these crosses were inherited normally, from the 
paternal lineage, we call them Ycs-pat and Ycon-pat. Crosses to obtain stocks with reverse 
sex chromosome inheritance resulting in males with identical genetics as Ycs and Ycon, 
but with a maternally inherited Y and paternally inherited X, are shown in Fig. S1. These 
crosses provided us with two other isogenic cultures from which we could sample Y 
chromosomes with sex-reversed inheritance, either Ycs-mat or Ycon-mat. Flies were 
grown under 12 hour light/dark temperature and humidity controlled incubators at 25 ºC.  
Males from the isogenic stocks were collected for use in microarray dye-swap 
experiments. Newly emerged males were collected 1-3 days post eclosion and allowed to 
age for 2 days at 25C, after which they were flash frozen in liquid nitrogen and stored at -
80C.  
 
Microarray hybridization and analysis. Our experiment consisted of 12 cDNA 
microarrays, involving 24 separate labeling reactions. Array design (Figure S2.2) was 
selected to optimize detecting interaction effects of Y chromosome and sex chromosome 
inheritance pattern (paternal-derived or maternal-derived Y). Microarrays were ~18,000-
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feature cDNA arrays spotted with D. melanogaster cDNA PCR products as described 
(Lemos et al. 2008). RNA extraction, cDNA synthesis, microarray hybridization, and 
microarray slide scanning protocols closely followed that of Lemos et al (Lemos et al. 
2008). Stringent quality-control criteria were used to ensure reliability of foreground 
intensity reads for both Cy5 and Cy3 channels. Foreground fluorescence of dye 
intensities was normalized by the Loess method implemented in the library Limma of the 
statistical software R. In cases where multiple probes map to a single FBgn, we selected a 
single probe for each FBgn by first selecting the probe that had good quality data on the 
most arrays, and then selecting the probe with the highest average expression level. In 
total, we included data from 5652 probes. Microarray gene expression data herein 
reported can be obtained at the GEO database (GSE42157).  
We fit a linear model using Limma method lmfit (Smyth 2004), with a design 
matrix parameterized to include a Dye term. To detect Y chromosome by parent of origin 
(Y-by-origin) interaction effects, we fit the contrast (Ycon-mat – Ycs-mat) – (Ycon-pat – 
Ycs-pat). Positive fold-change values represent higher relative expression in Ycon 
compared to Ycs males when sex chromosome inheritance is reversed (maternal-derived 
Y), than when sex chromosome inheritance is normal (paternal-derived Y). We call these 
Type 1 interaction effects. Negative fold-change values represent the reverse trend. We 
call these Type 2 interaction effects. All P values from Limma are adjusted for multiple 
testing using the false discovery rate (FDR) approach (Benjamini and Hochberg 1995). 
We focus on the 20% FDR dataset, because it aligns with similar FDR cut-offs used by 
us in the past, but our conclusions are not substantially affected by using a different 
cutoff. 
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Gene expression datasets. Tissue-specific gene expression patterns were downloaded 
from FlyAtlas, and the tissue specificity of each gene was ascribed as outlined in 
(Sackton et al. 2011). The measure of tissue specificity index ranges from 0 if a gene is 
not expressed in a tissue, to 1 if a gene is exclusively expressed in a tissue. A gene is 
defined as being specific to a tissue when the tissue specificity is > 0.9.  
Male and female-biased gene expression data were downloaded from SEBIDA 
(Gnad and Parsch 2006). In the SEBIDA meta-analysis of relative expression level of 
genes in males and females, a 2-fold cut-off and FDR > 0.2 was used to assign genes to 
categories of male-biased or female-biased. Male-fitness, female-fitness, and sexually-
antagonistic fitness genes were those identified by Innocenti and Morrow (Innocenti and 
Morrow 2010) to be associated with fertilization success in males and females, under 
competitive conditions.  
 
GO Enrichment. Enriched GO categories were identified with the term-enrichment tool 
available as part of AmiGO (http://amigo.geneontology.org), using a Bonferroni-
corrected P-value cutoff of 0.05, and using the set of 5652 probes passing our quality 
control filters as background set. 
 
Quantitative-PCR. We used the non-LTR retrotransposon element R2 to determine the 
level of rDNA transcription. R2 retrotransposons insert specifically into the 28S rRNA 
gene and are cotranscribed with the rRNA units, and thus can be used as a sensitive 
marker for rDNA transcription. R2 was amplified with primers 5’- 
 48 
TTGAGAGCAGAGGGGGAGTA-3’ and 3’- GTTTAGCATTACCGGGACCA-5’. For 
quantitative analysis, three to four biological replicates of 60 adult flies each were 
sampled in each genotype. qPCR analyses were carried out with Fast Sybr Green Master 
Mix (Applied Biosystems). cDNA synthesis was done with Quantitect Reverse-
Transcription Kit (Qiagen). Real-time PCR profiles were obtained with 7900HT Fast 
Real-Time PCR (Applied Biosystems). Beta-tubulin expression level was used as control. 
 
PEV assay. Two sets of males were produced. 1) Males with Ycs or Ycon were crossed to 
females from a stock carrying the white eye-color gene w[m4h] to produce male progeny 
variegating for white, and with a paternally inherited Y. 2) Females (with compound X 
chromosome and Y) from the populations containing Ycs-mat and Ycon-mat were crossed 
to males from the same w[m4h] stock to produce male progeny also variegating for 
white, but with a maternally inherited Y. Cross designs are shown in Figure S2.3. Flies 
from this strain possess an inversion on the X chromosome that repositions the white gene 
proximal to the X centromere. Due to its new location near the heterochromatin-
euchromatin boundary, w[m4h] experiences variegated gene silencing, resulting in eye-
color mosaicism of mottled white and red eye spots. Flies were maintained at 25 ºC. 
Males from these crosses were collected, aged for 2 days at 25 ºC, flash frozen in liquid 
nitrogen, and stored at -80 ºC. Heads of males were removed with a blade and 
homogenized 4 to a tube of 10 uL of acidified ethanol (30% ethanol acidified to pH 2 
with HCl). Eye pigment expression was assessed with spectrophotometric analysis at an 
optical density of 280 nm. Four to six biological replicates were used per treatment, with 
two technical replicates per biological replicate. Males displaying typical eye-
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pigmentation phenotypes were imaged using an automontage system (Syncroscopy, 
Frederick, MD).   
To test whether maternal aneuploidism, rather than maternal transmission of the Y 
chromosome, was a major contributor to PEV effects, we performed crosses outlined in 
Supplementary Figure S2.4. Briefly, males inherited identical Y chromosomes either 
maternally from attached-XX/Y mothers, or paternally from XY males (as normal), but 
also had genetically XXY mothers (in this case they were attached-XY/X). If maternal 
versus paternal transmission of the Y chromosome was a major contributor to differential 
PEV expression, then we would expect to see differences in PEV for these males. If 
maternal aneuploidism (XXY) versus normal XX maternal effects were the cause of 
major PEV differences, we would not see differential PEV phenotypes since both males 
had XXY mothers.  
 
 
RESULTS 
Y-regulatory variation is modulated by parent -of-origin of the Y chromosome. 
Previous work suggested that hundreds of genes are under the regulatory control of the Y 
chromosome in Drosophila melanogaster (Lemos et al. 2008; Jiang et al. 2010; Sackton 
et al. 2011), but the mechanism of such regulation remained elusive. Here, we show that 
males inheriting a Y chromosome from their father, and an X from their mother, showed 
differential YRV in both magnitude and scope of genes affected. At false discovery rates 
FDR < 0.2, males possessing either Ycon or Ycs through normal sex chromosome 
inheritance (Ycon-pat vs Ycs-pat) showed differential expression of 242 genes, while the 
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difference between males with Ycon or Ycs acquired through maternal inheritance (Ycon-
mat vs Ycs-mat) showed differential expression of only 11 genes. The number of genes 
showing significant Y-by-origin interaction, representing genes which show significantly 
increased, decreased, or reversed magnitudes of differential expression between Ycs and 
Ycon males depending on paternal or maternal inheritance patterns, totaled 392 genes. 
Overlap of differentially expressed gene sets between these three contrasts totals 3 genes, 
as shown in Figure 2.1. These results suggest that epigenetic modifications established 
during transmission of sex chromosomes differs between males and females, with 
important implications for YRV.  
Our observation of reduced Y-linked regulatory variation between males carrying 
polymorphic Y chromosomes inherited from their mothers may be explained by an 
overall paternal imprint on the Y in Drosophila, which leads to increased 
heterochromatinization of the chromosome (Golic et al. 1998; Maggert and Golic 2002). 
When Y chromosomes are maternally inherited instead, heterochromatinization may be 
reduced. In light of the hypothesis that chromatin-based regulation by the Y is mediated 
by repeated sequences acting as a sink for chromatin-associated proteins, maternally 
inherited Y chromosomes may not modulate chromatin dynamics as pervasively as 
paternally inherited Y chromosomes. The limited role of maternally inherited Y 
chromosomes as modifiers of global gene expression is not surprising, given that Y 
chromosomes in Drosophila normally never pass through the female lineage. 
 51 
 
Figure 2.1. Venn diagram showing number of differentially regulated genes between Ycs 
and Ycon males with sex chromosomes inherited normally (X-mat, Y-pat) or reverse (X-
pat, Y-mat) (left and right top circles). Lower circle represents genes which show 
significant Y-by-origin interaction effects. 
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We propose that the 392 genes showing Y-by-origin interaction effects represent 
genes which show differential Y-regulatory variation because of an imprint on the Y 
caused by its parent-of-origin. They can be subdivided into two categories (outlined in 
Methods), depending on their expression patterns: 1) Type 1 interaction effects represent 
higher relative expression in Ycon compared to Ycs males when sex chromosome 
inheritance is reversed (maternal-derived Y), than when sex chromosome inheritance is 
normal (paternal-derived Y), 2) Type 2 interaction effects lower relative expression for 
the same contrast. There were 247 genes showing Type 1 effects, and 145 genes showing 
Type 2 effects. A heat map of the relative expressions of these genes across the four Y-
by-origin combinations is presented in Figure 2.2, with a heuristic representation of 
“Type 1” vs “Type 2” interaction effects shown for illustrative purposes. Figure 2.3 
shows expression patterns of the three genes identified to show differential gene 
expression in all three contrasts (three-way overlap in Figure 2.1 Venn diagram). These 
three genes are CG1979, a gene with unknown molecular function that has high 
expression in male testis; a gene for ribosomal protein S10b, a constituent of ribosomes; 
and a gene for adult cuticle protein 65Aa, a constituent of chitin-based cuticle. 
Approximately 45%, 42%, 12%, and <1% of the genes showing Y-by-origin interaction 
effects can be assigned to genes on the second, third, X, and fourth chromosomes, 
respectively. These percentages  do not differ significantly from expectations based 
solely on gene content (chi-square test, chi-square = 0.39, P value = 0.94). 
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Figure 2.2. Left: A heat map of relative expression levels of 392 genes showing 
significant Y-by-origin interaction effects. Red denotes low expression while green 
denotes high. Genotypes are given for each column at the top. Rows represent genes. 
Genes above the dashed line (right panel) demonstrate what we term a “Type 1” 
interaction effect, while genes below the dashed line demonstrate a “Type 2” interaction 
effect. Right: Cartoon gene expression patterns of two example genes are given for a 
heuristic illustration of what these labels for Type 1 and Type 2 interaction gene 
expression patterns represent. Y-axis shows normalized gene expression expression. X –
axis shows the parent of origin of the Y, which is inherited either paternally (Y-pat) or 
maternally (Y-mat)
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Figure 2.3. Normalized expression levels of Ycon and Ycs males inheriting their sex 
chromosome either paternally or maternally. CG1979 shows Type 1 interaction effects, 
the gene for ribosomal protein S10b shows Type 2 interaction effects, and the gene for 
adult cuticle protein 65Aa shows Type 1 interaction effects. 
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Table 2.1. Significantly over-represented Gene Ontology (GO) categories among genes 
showing Type 2 Y-by-origin interaction effects. P-values are adjusted for multiple 
hypothesis testing. There are no GO categories significantly enriched among genes 
showing Type 1 interaction effects. 
Category Description P-value Sample 
frequency 
Background 
frequency 
Biological Process    
  GO: 0006412 translation 7.47E-04 22/120 (18.3%) 252/4473 (5.6%) 
Cellular Component    
  GO:0044391 ribosomal subunit 8.3E-07 19/120 (15.8%) 128/4473 (2.9%) 
  GO:0005840 ribosome 1.43E-06 19/120 (15.8%) 132/4473 (2.9%) 
  GO:0030529 ribonucleoprotein 
complex 
6.12E-05 24/120 (20.0%) 258/4473 (5.8%) 
  GO:0015934 large ribosomal subunit 1.27E-04 13/120 (10.8%) 78/4473 (1.7%) 
  GO:0022626 cytosolic ribosome 4.07E-04 12/120 (10.0%) 72/4473 (1.6%) 
  GO:0044445 cytosolic part 7.69E-03 12/120 (10.0%) 94/4473 (2.1%) 
 
  GO:0022625 cytosolic large ribosomal 
subunit 
2.16E-02 8/120 (6.7%) 44/4473 (1.0%) 
  GO:0005576 extracellular region 4.11E-02 19/120 (15.8%) 252/4473 (5.6%) 
Molecular Function    
  GO:0003735 structural constituent of 
ribosome 
1.25E-06 19/120 (15.8%) 131/4473 (2.9%) 
  GO:0005198 structural molecule 
activity 
1.28E-04 21/120 (17.5%) 209/4473 (4.7%) 
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Gene expression patterns for genes showing positive Y-by-origin interaction effects 
are involved in ribosome formation and male-specific functions. Gene ontology 
analysis revealed a functionally cohesive story in regard to which categories were 
enriched for genes showing Y-by-origin interaction effects (Table 1). Genes showing 
Type 1 interaction effects are functionally distinct from those showing Type 2 interaction 
effects. Genes in the Type 2 interaction effects group show functional cohesiveness, and 
are enriched in GO categories related to ribosome function or whose products localized to 
ribosomal subunits. This pattern of enrichment of rDNA-based functional units again 
underlies the importance of heterochromatin and chromatin structure to Y chromosome 
regulation. rDNA transcription is necessary for heterochromatin formation, and indicative 
of overall heterochromatinization of the genome (Peng and Karpen 2007; Larson et al. 
2012). 
Although no GO categories are significantly over-represented among genes in the 
Type 1 interaction effects group, we do find other interesting patterns of gene expression. 
For example, genes showing positive interaction effects are more likely to be testis 
specific than genes showing no or negative interaction effects (Figure 2.4). This is in 
agreement with previous findings (Lemos et al. 2008; Sackton et al. 2011) of strong YRV 
effects on male-specific genes and genes associated with spermatogenesis. Based on 
SEBIDA’s meta-analysis on genes which show sex-biased expression (Gnad and Parsch 
2006), genes showing Type 1 interaction effects were more likely to be enriched for 
genes that are male biased, and conversely, diminished for genes that are female biased 
(Figure 2.5a; Chi-sq test,  χ2 = 25.18,  P value = 3.4e-06). Genes showing Type 2 
interaction effects did not differ from neutral expectations (Figure 2.5b; chi-square test,  
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χ2 = 0.026,  P value = 0.99). In concordance with this finding that male-specific traits are 
affected, we found that genes known to be associated with male fitness (Innocenti and 
Morrow 2010) are overrepresented among genes identified to have the largest interaction 
effects (mean-rank gene set enrichment test, P = 0.031).  
 
Figure 2.4. Genes showing Type 1 Y-by-origin interaction effects are much more likely to 
be testis specific than genes showing a Type 2 and no interaction effects. Horizontal line 
represents the expected proportion of testis-specific genes. Fisher’s exact test, two-tailed, 
P = 1.46e-06. 
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Figure 2.5. (A) Genes showing a Type 1 Y-by-origin interaction effect are enriched for 
male biased genes, but impoverished for female biased genes. (B) Genes showing a Type 
2 interaction effect show no deviation from expectation for male biased, female biased, 
and unbiased genes. 
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Figure 2.5 (continued). 
 60 
Parental origin of sex chromosomes affects Y-regulated position effect variegation 
and rDNA transcription levels. The above results from microarray data suggesting Y-
by-origin interaction effects on gene expression were also observed in a heterochromatin-
related phenotype: position effect variegation (PEV). Males in this assay possessed either 
Ycon or Ycs in a hybrid genetic background consisting of white-eye mutation w[m4h] 
positioned near the X chromosome euchromatin-heterochromatin boundary, a haploid 
autosomal genome sampled from the original stock containing the PEV marker, and a 
haploid autosomal genome sampled from the B4361 laboratory population. An additional 
factor was inheritance of sex chromosomes, which was either normal (Xmat, Ypat) or 
reversed (Xpat, Ymat). Reversed sex chromosome inheritance was achieved by crossing 
XXY females (carrying Ycs or Ycon) with XY males carrying the white mutation. PEV has 
previously been shown to be affected by variation in the Y (Jiang et al. 2010; Lemos et al. 
2010). We observed that Y-regulated PEV differs depending on the parent of origin of the 
Y chromosome (Figure 2.6a; ANOVA, df = 1, F = 9.05, P = 0.009), with Ycs-mat males 
showing a marked reduction of heterochromatic-linked silencing (reduced PEV - thereby 
increasing expression of white and displaying redder eyes) compared to Ycon-mat males, 
when sex chromosome inheritance was reversed. When sex chromosome inheritance is 
normal, Ycs-pat males showed slightly higher expression of white than Ycon-pat males, in 
accordance with previous studies (Lemos et al. 2010). The effect of Y imprinting on PEV 
and rDNA transcription levels is dependent on the specific Y chromosome, as it decreases 
PEV (resulting in redder eyes) and increases rDNA transcription in Ycs males under 
maternal imprinting, while it has no, or even the opposite, effect in Ycon males. 
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Figure 2.6. (A) Y-by-origin interaction effects on PEV. Eye pigmentation was measured 
as absorption of light at 480 nm. Heads of representative males are shown. (B) 
Normalized real-time PCR of retrotransposon R2 expression, a marker of rDNA 
transcription, in Ycs and Ycon males inheriting their sex chromosomes paternally or 
maternally. Beta-tubulin expression levels was used as a control. 
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Figure 2.6 (continued). 
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Interestingly, Y-by-origin interaction effects on rDNA transcription levels mirror 
closely the PEV results, reinforcing the possibility that epigenetic modifications on the Y 
during parent to offspring transfer of genetic material may modify a suite of expression 
pattern differences. However, the Y-by-origin interaction effect on rDNA transcription is 
not significant (Figure 2.6b; ANOVA, df = 1, F = 0.80, P = 0.39), so the parallelism 
could be coincidental.  
In addition, we observed that males inheriting their Y’s maternally had expressed 
lower levels of PEV than males inheriting their Y’s paternally. In contrast to our main 
PEV study, both these males had genetically XXY mothers (Supplementary Figure S2.5). 
Thus, paternal versus maternal transmission of the Y chromosome, rather than maternal 
aneuploidism, is likely the main cause of differential PEV expression. 
 
DISCUSSION 
 Our results show that imprinting of the Y chromosome in Drosophila 
melanogaster affects Y-linked regulatory variation in hundreds of genes, as well as 
position effect variegation (PEV), a heterochromatin-linked phenotype. Convincing 
evidence of Y imprinting in this species has been previously reported. This imprint has 
usually been detected through expression of genes located on the same chromosome as 
the imprint, for example, that of the rearranged Dp(1;f)LJ9 mini-X chromosome (Anaka 
et al. 2009), and P-element marker insertions on the Y chromosome (Haller and Woodruff 
2000; Maggert and Golic 2002). Recently, the imprint effect of the Y chromosome has 
been expanded to include dosage compensation, which is targeted to a chromosome other 
than the one bearing the imprint (Menon and Meller 2009). Here, we present novel 
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evidence that imprinting of the Y chromosome affects not only proximal genes on the 
same chromosome, or a dosage effect on the Y, but also the expression of a large set of 
autosomal and X-linked genes, many of which have important functional consequences 
for males.  
The biological relevance of the Y chromosome imprint, however, remains unclear 
as Y chromosomes are inherited uniparentally in nature. Furthermore, males are fertile 
whether Y’s are transmitted from mothers or fathers, so the imprint is not essential for 
spermatogenesis or viability.  
A link between imprinting and heterochromatin exists in Drosophila. Imprinting 
in Drosophila seems to be associated only with heterochromatin or regions with unusual 
chromatin structure (Lloyd 2000), such as pericentromeric heterochromatin and the Y 
chromosome. Furthermore, genes implicated in the regulation of imprinting, such as 
Su(var)3-9 histone 3 methyl transferase and heterochromatin protein 1 (HP1) are also 
known to be important regulators of heterochromatin formation (Joanis and Lloyd 2002). 
Therefore, our finding of an imprint effect on Y-regulatory variation further strengthens 
the hypothesis that Y-regulated gene expression on the autosomes and X chromosome is 
exerted by the polymorphic functions of Y chromosomes through manipulation of global 
chromatin dynamics, perhaps by acting as a sink for a limited pool of chromatin 
remodeling proteins.  
  Multiple lines of evidence support the hypothesis that repeated sequences serve 
as a sink for some chromatin-associated proteins, including observations in mice that 
transcription factor C/EBP alpha binds to satellite repeats (Liu et al. 2007) and also in 
fruit flies, where enhancer-trap analysis revealed a trans regulator of lacZ reporter 
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expression localizing to functionally redundant and spatially dispersed bands on the Y 
chromosome which coincide with GAGA transcription factor binding motifs (Zhang et al. 
2000). Finally, Lemos et al ((Lemos et al. 2010)) found that XXY females carrying 
polymorphic Y’s showed differential expression of many genes involved with 
chromosome organization and chromatin assembly. Since XXY females do not transcribe 
Y protein-coding genes, this further supports the hypothesis that Y-linked regulatory 
variation is driven primarily by non-coding, repetitive variation buried in 
heterochromatin. The Y-as-chromatin-sink hypothesis, together with the observation that 
Y chromosomes harbor a plentitude of structural, repeat-based variation, suggests that Y-
linked polymorphic phenotypic effects may be caused by differential binding of gene 
regulators by different Y chromosomes. This in turn leads to differential titration of these 
proteins at other genomic loci, and facilitates differential gene expression at these loci. In 
accordance with this hypothesis, observations of an imprint on Y affecting dosage 
compensation has led to speculation that the imprint could modulate the Y’s ability to 
bind chromatin proteins at a critical time during dosage compensation (Menon and Meller 
2009). The link between the Y chromosome and chromatin proteins can be extended in 
humans, where Y-chromosome linked repeats are hypomethylated in mutants with 
compromised global chromatin remodeling (Gibbons et al. 2000).  
 In general, heterochromatin formed in response to an imprint affects adjacent 
regions to generate blocks of differential expression according to parent-of-origin (Anaka 
et al. 2009). The direction of the imprint seems to be mostly paternal imprint, at least for 
eye and body coloration phenotypes. Studies of the Dp(1;f)LJ9 mini-X chromosome by 
Anaka et al. (2009) ((Anaka et al. 2009)) found it to be paternally imprinted, with males 
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exhibiting decreased expression of y. Maggert and Golic ((Maggert and Golic 2002)) also 
found that for 21 out of 22 Y-linked P-element marker genes they examined, imprint-
regulated expression showed the same pattern: paternal inheritance led to reduced 
expression. We could not test for direct expression of Y-linked genes with our experiment 
because the number of genes is small, and these did not pass quality control filtering. 
However, results from our PEV assay seem to partially confirm this result: Ycs-mat males 
derived from reverse sex chromosome inheritance crosses (Y-maternal, X-paternal) 
showed higher expression of the white marker gene. However, Ycon males did not show 
differential expression of white between males inheriting their Y-chromosomes 
maternally and those inheriting them paternally. In fact, we would not necessarily expect 
to see a similar pattern of reduced expression due to paternal-imprint because of higher-
level regulatory processes between an imprinted chromosome (in this case, the Y), and 
expression on other chromosomes (in this case, the X) in our experiment. In contrast, 
previous studies had only looked at imprint effects on genes located on the same 
chromosome as the chromosome of imprint. 
 Studies of hybrid lethality between Drosophila species may provide clues to the 
adaptive significance of Y regulatory variation modulated by Y-imprinting. First, hybrid 
lethality and heterochromatin have been linked in previous studies (Brideau et al. 2006; 
Pal Bhadra et al. 2006). Second, Menon and Meller (2009) ((Menon and Meller 2009)) 
found that paternally transmitted Y chromosomes dramatically lowers survival in males 
harboring mutations in roX1 and roX2, genes necessary for forming the male-specific 
lethal complex in males responsible for dosage compensation. They proposed that roX 
mutations may mimic a defect in dosage compensation that occurs in interspecies 
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hybrids, and paternal imprinting of the Y is adaptive as it lowers the survival of unfit 
hybrids (Wu and Ting 2004). Third, in support of this hypothesis, genes under the 
influence of Y-linked polymorphism regulation are highly divergent in expression 
between species (Lemos et al. 2008), and interspecific Y chromosome introgressions led 
to reduced male fecundity and sperm competitive ability (Sackton et al. 2011). Therefore, 
a paternal imprint is expected to enhance the regulatory ability of the Y chromosome. We 
find agreement with this hypothesis of a male-adapted paternal imprint on the Y within 
our own data: a particular subset of genes showing Y-by-origin interaction effect were 
enriched for high, specific expression in testis, were more male biased than expected, and 
were associated with male fitness. In addition, when the Y was inherited from mothers, it 
lost much of its regulatory ability. 
 Another indication that Y chromosome imprinting results in chromatin state 
remodeling within the cell is the pattern of rRNA synthesis we observed, as quantified by 
qPCR. Although the interaction effect is not significant, we saw that rRNA transcription 
levels were modified by reverse sex chromosome inheritance. Previous studies found that 
rDNA arrays are necessary for heterochromatin formation through two lines of evidence: 
heterochromatin formation is disrupted in rDNA array mutants (Peng and Karpen 2007) 
and deletions of the rDNA array results in decreased heterochromatin composition of the 
genome, and affects gene expression elsewhere in other heterochromatin regions of the 
genome (Paredes and Maggert 2009). rDNA transcriptional variation is known to be 
correlated with PEV (Paredes and Maggert 2009; Zhou et al. 2012), presumably because 
it reflects alteration of chromatin states within the cell, and PEV is a heterochromatin-
linked phenotype. We also observe a marked similarity between rRNA expression and 
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PEV phenotype in our results. In further support of this pattern, Larson et al (2012) 
((Larson et al. 2012)) found that increased rRNA transcription indicates a reduced 
heterochromatic state in the genome. The effect of this on PEV would be to disrupt 
heterochromatin-induced silencing (reduced variegation), and thus increase expression of 
white, producing redder eyes. In support of our findings of a significant role for rDNA 
arrays in YRV, Paredes et al (Paredes et al. 2011) recently showed that Y-linked rDNA 
polymorphism modifies the expression of genes in euchromatic components of the D. 
melanogaster genome, and that these genes overlap significantly with genes affected by 
natural Y chromosome polymorphisms. 
The potency of Y imprint affecting male-specific functions, and regulating global 
gene expression, is likely not limited to Drosophila. The role of the Y as a genomic 
regulatory element has been convincingly demonstrated in murine models. Xu et al ((Xu 
et al. 2012)) reported that presence of the Y, but not absence of the second X-
chromosome, in XY sex-reversed females, alters expression of hundreds of genes. Singer 
et al ((Singer et al. 2004)) identified the Y chromosome to have a phenotypic effect 
similar to autosomes in a suite of development, physiological, and behavioral processes 
using chromosome substitution strains. Intriguingly, epigenetic regulation of the Y 
chromosome may even be transgenerational, as a father’s Y chromosome influences 
quantitative traits in his daughters, who do not carry Y’s, a result first noted in mice 
((Nelson et al. 2010), and later confirmed in Drosophila (Friberg et al. 2012). The 
possibility of Y regulatory variation enhanced by Y-imprint in mammals is not unlikely, 
given that common epigenetic mechanisms regulate diverse imprinted domains in 
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animals, plants, and insects (reviewed in (MacDonald 2012)); however no known 
mammalian Y chromosome imprint has yet been observed.  
 As a cautionary note, the effects we see might not be ascribed only to parent-of-
origin of the Y. One alternate explanation for the differential regulatory and PEV effects 
of the Y chromosome is that males with paternally versus maternally inherited Y’s also 
had XX versus XXY mothers. We see that for PEV, this explanation is not satisfactory, 
as males showed differential expression of an X-linked wm4h gene when the Y 
chromosome was inherited paternally or maternally (Supplementary Figure S2.5), even 
though ploidy of mothers remained constant (XXY in both cases). Position effect 
variegation and chromatin structure are closely related, since genes that influence PEV 
have been found to encode for structural components of chromatin, which in turn 
regulates the expression and repression of genes (Henikoff et al. 1992). Thus, although 
we cannot directly test for the effect of XXY aneuploidism on Y-regulatory effects, we 
believe maternal aneuploidism plays at most a small role in contrast to the large, 
demonstrated role of Y-imprinting via parent-of-origin transmission. A second 
explanation may be that the paternal transmission of the X exerts a strong influence, and 
that X-imprinting may lead to these results. This may be particularly relevant to the 
discussion of male versus female-based genes, as the X has been theorized to be a hot 
spot for sex-specific evolution (REF). If gene expression changes were the result of cis-
regulatory control due to imprinting on the X, we would expect to see an over-
representation of X-linked genes showing differential expression due to pattern of 
inheritance alone (normal versus reverse), irrespective of Y chromosomes. However, 
since we see no such pattern (genes localize to the X, 2nd, 3rd , and 4th chromosomes at 
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12%, 49%, 38%, and < 1%, which does not differ from a random distribution based on 
gene densities, P = 0.139), we believe paternal transmission of the X cannot explain the 
pattern we see. 
 Our results support the hypothesis of Y-linked heterochromatic polymorphisms 
operating via chromatin remodeling to facilitate adaptive evolution of a suite of genes 
associated with male-specific functions. Such epigenetic regulation of gene expression, 
together with previous studies of the nontransitivity of sperm competition (Clark et al. 
2000) and Y-by-background interactions for both male fitness (Chippindale and Rice 
2001) and global gene expression (Jiang et al. 2010) highlight complex mechanisms for 
maintaining Y-polymorphisms responsible for regulating differential expressivity and 
variation in ecologically important traits. 
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ABSTRACT 
Antifolate antimalarials, such as pyrimethamine, have experienced a dramatic reduction 
in therapeutic efficacy as resistance has evolved in multiple malaria species. We present 
evidence from one such species, Plasmodium vivax, which has experienced sustained 
selection for pyrimethamine resistance at the dihydrofolate reductase (DHFR) locus since 
the 1970s. Using a transgenic Saccharomyces cerevisiae model expressing the P. vivax 
DHFR enzyme, we assayed growth rate and resistance of all 16 combinations of 4 DHFR 
amino acid substitutions. These substitutions were selected based on their known 
association with drug resistance, both in natural isolates and in laboratory settings, in the 
related malaria species P. falciparum. We observed a strong correlation between the 
resistance phenotypes for these 16 P. vivax alleles and previously observed resistance 
data for P. falciparum, which was surprising since nucleotide diversity levels and 
common polymorphic variants of DHFR differ between the two species. Similar results 
were observed when we expressed the P. vivax alleles in a transgenic bacterial system. 
This suggests common constraints on enzyme evolution in the orthologous DHFR 
proteins. The interplay of negative trade-offs between the evolution of novel resistance 
and compromised endogenous function varies at different drug dosages, and so too do the 
major trajectories for DHFR evolution. In simulations, it is only at very high drug 
dosages that the most resistant quadruple mutant DHFR allele is favored by selection. 
This is in agreement with common polymorphic DHFR data in P. vivax, from which this 
quadruple mutant is missing. We propose that clinical dosages of pyrimethamine may 
have historically been too low to select for the most resistant allele, or that the fitness cost 
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of the most resistant allele was untenable without a compensatory mutation elsewhere in 
the genome.  
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INTRODUCTION 
The development of effective clinical therapeutics relies on an understanding of 
the molecular evolution of drug resistance. Factors which may affect evolutionary 
pathways of resistant alleles are drug concentration, epistatic interactions between 
mutations within the same gene, mutation bias in the genome, and adaptive conflict over 
resistance and function (Peterson, Walliker, and Wellems 1988; Snewin et al. 1989; 
Looareesuwan et al. 1996; Wellems 2002). The malaria parasite presents a unique 
opportunity for studying the constraints that a fitness landscape may impose on the 
evolution of an organism as it has historically undergone waves of strong selection for 
drug resistance. These waves have been marked by the introduction, and eventual 
compromised efficacy, of a changing arsenal of first-line malaria drugs, including 
chloroquine, atovaquone, and pyrimethamine (Breman 2012). Artemisenin-combination 
therapies (ACTs) are the last line of defense for the treatment of malaria, but signs of 
resistance building in small pockets of Southeast Asia demonstrates pervasive selection 
for resistance, and highlights the importance of understanding the molecular basis of 
resistance evolution (Kepler and Perelson 1998).  
Drug concentration is considered critical for the selection of drug resistance in 
infectious agents such as HIV (White et al. 2009) and malaria (Kepler and Perelson 1998; 
Weinreich et al. 2006; Lozovsky et al. 2009; Brown et al. 2010; Chou et al. 2011).  
Varying concentrations of drugs have varying potential to facilitate resistance: there is no 
selection for resistance if drug concentrations are high enough to kill all sensitive and 
resistance parasites, or too low to kill either. Thus, the window of drug concentrations 
that allows evolution of resistant variants is relatively narrow (Peterson et al. 1988; 
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Snewin et al. 1989; Looareesuwan et al. 1996; Wellems 2002; Weinreich et al. 2006). A 
second factor to constrain evolutionary trajectories of resistant phenotypes is epistasis 
among multiple mutant sites in the same gene: the effect of any amino acid replacement 
may be dependent on the genetic context in which it finds itself, for example the same 
mutation may increase resistance on some backgrounds but decrease it in others. This 
type of non-additive interaction is termed sign epistasis, and has been reported in multiple 
instances, including beta-lactamase in Escherichia coli (Weinreich et al. 2006) and 
dihydrofolate reductase in Plasmodium falciparum (Brown et al. 2010). Another factor, 
mutation bias, can restrict the likelihood of fixation of a mutation (however favorable it 
may be) by limiting the likelihood of de-novo mutations to a particular base. For 
example, the genome of P. falciparum is strongly biased toward AT, and AT-rich codons 
are thus favored over others (Depristo, Zilversmit, and Hartl 2006). Finally, adaptive 
conflict can constrain evolutionary pathways because amino acid replacements which 
confer high resistance can come at a fitness cost by impairing endogenous functioning of 
the protein in the absence of drug (Sirawaraporn et al. 1997), although such negative 
trade-offs are not always necessary (Aharoni et al. 2005; Kondrashov 2005). 
In this study, we focus on the malaria parasite Plasmodium vivax and the 
evolution within this species of drug resistance to pyrimethamine, a drug that 
competitively inhibits dihydrofolate reductase (DHFR). DHFR is a parasite enzyme 
required for the synthesis of tetrahydrofolate, an essential precursor of purines and 
several amino acids (Kompis, Islam, and Then 2005). Although P. vivax is not normally 
treated with pyrimethamine directly, the high frequency of mixed infections with P. 
falciparum (which has been treated by the combination drug sulfadoxine-pyrimethamine 
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since the 1970s), has exposed a large number of P. vivax parasites to selection for drug 
resistance in many areas. P. vivax is remotely related to P. falciparum, the two having 
diverged approximately 100 million years ago (Ayala, Escalante, and Rich 1999; Carter 
2003). The life cycle of P. vivax features a latent liver infection responsible for relapses 
months or years following the initial infection. Although seldom fatal, P. vivax elicits 
incapacitating clinical symptoms and recurrent severe relapses. Recent work suggests that 
the morbidity and mortality associated with these cycles of reinfection are greater than 
previously believed (Mendis et al. 2001; Sina 2002).  
The combination of a long history of pyrimethamine use and the common co-
infection of P. vivax and P. falciparum has facilitated the evolution of drug resistance in 
both species. Point mutations in the dhfr gene and their impact on sensitivity of P. 
falciparum to pyrimethamine have been studied extensively in vitro and in vivo (Wooden 
et al. 1997; Cortese and Plowe 1998; Randrianasolo et al. 2004). However, similar data 
for P. vivax is lacking due to the difficulties associated with culturing this species in the 
laboratory.  
The active site regions of DHFR in P. vivax and P. falciparum are strongly 
conserved, despite the two proteins preserving only ~66% sequence identity (Kongsaeree 
et al. 2005). The dhfr coding region is encoded by about 700 nucleotides in both species. 
However, work in P. falciparum shows that only a limited number of mutations are 
associated with drug resistance. Mutations at codons 16, 50, 51, 59, 108, and 164 have 
been observed to affect resistance in pyrimethamine, or the related antifolate drugs 
cycloguanil or chlorcycloguanil, in P. falciparum isolates from around the world (Sibley 
et al. 2001; Gregson and Plowe 2005; Hyde 2005). Four of these mutations (N51I, C59R, 
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S108N, and I164L) were found to be most commonly associated with drug resistance, 
and were extensively studied by Lozovsky et al. (Lozovsky et al. 2009) to predict favored 
pathways of drug resistance based on empirical estimates of mutational spectrum and 
probabilities of fixation based on relative levels of resistance. Although far fewer isolates 
of P. vivax have been studied, numerous alleles of dhfr have been identified, which is in 
contrast to the lack of diversity in P. falciparum (Hawkins et al. 2008).  
Sequence alignment indicates that the four mutations important to pyrimethamine 
resistance in P. falciparum DHFR (N51I, C59R, S108N, and I164L) correspond to 
mutations N50I, S58R, S117N, and I173L in P. vivax DHFR. Interestingly, mutations at 
these exact codons have been observed in natural P. vivax isolates, suggesting that P. 
falciparum and P. vivax DHFR may experience similar functional and selective 
constraints despite approximately 100 million years of divergence. However, the story 
may not be so simple, as mutations which are common and convey high resistance in P. 
falciparum, such as I164L, are rarely observed in P. vivax (where the homologous 
mutation is I173L). Therefore, evolutionary trajectories of mutation acquisition by the 
two proteins may differ more than expected. 
The goal of this experiment was to assay whether these four point mutations in 
DHFR, which in P. falciparum have been demonstrated to convey drug resistance and 
mold the evolutionary landscape of mutation acquisition, have similar effects in P. vivax. 
The mutational landscape in DHFR differs between P. falciparum and P. vivax quite 
extensively, with far greater polymorphism in the latter species. Some mutations which 
are commonly observed in P. vivax, which are not included in the set we have studied, 
include F57I, T61M, and S117T. Due to this, the emphasis of our study is not on practical 
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applications of the results in a clinical setting, but rather to test whether orthologous 
amino acid replacements in orthologous proteins have parallel effects. And to apply a 
forward-time approach (rather than traditional coalescent models) to simulate 
evolutionary trajectories that use fitness landscapes informed by multiple parameters such 
as drug concentration, direct selection coefficients, and drift (rather than IC50 alone). 
Using a transgenic yeast system, we explored the mutational landscape of 
pyrimethamine resistance in P. vivax DHFR. Following others (Weinreich et al. 2006; 
Lozovsky et al. 2009; Brown et al. 2010) we genetically engineering all 16 possible 
combinations of 4 amino acid replacements. Each of these mutations has been observed 
in various combinations in nature and shown to be associated with drug resistance. 
Fitness landscapes and stepwise mutational trajectories can be predicted by analyzing the 
phenotypes of these alleles in the presence of the drug. Importantly, trade-offs between 
novel function (resistance) and existing function (activity) can be gauged simultaneously 
by translating growth rates at various drug concentrations into proportional fitness peaks 
and valleys in the resulting landscape.  
Overall, our results provide the first predicted pathways of mutation acquisition in 
the dhfr gene in P. vivax. Importantly, these pathways are given for a gradient of drug 
concentrations, which can represent a temporally and spatially heterogeneous drug 
reservoir within the population created by sporadic noncompliance to antibiotic regimes, 
varying dosage regimes, or compartmentalization of drugs in different tissues. We show 
that varying drug concentrations affect the fitness of the most resistant alleles. In other 
words, adaptive fitness landscapes are strongly molded by drug concentrations. The 
landscape is dominated by the single peak of the non-mutant allele at the low end of drug 
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concentration spectrum, and is effectively flat (and without a single peak) for very high 
drug concentrations. Medium-range drug concentrations have distinctly different 
projected evolutionary trajectories, and the selectivity window for the most resistant 
quadruple mutant is constrained within a narrow range. Second, P. vivax DHFR shows 
sign epistasis at multiple mutation sites, which explains why many evolutionary pathways 
are rendered inaccessible to selection in our scenarios. Finally, to address the ability of 
adaptive conflict to influence evolution, we used a composite measure of resistance and 
endogenous function, both of which determine fitness, to represent the nodes in our 
fitness landscapes. This is in contrast to previous studies that primarily relied on 
resistance only to construct adaptive landscapes (Weinreich et al. 2006; Lozovsky et al. 
2009; Brown et al. 2010).  
 
METHODS AND MATERIALS 
E.coli and yeast strain construction 
P. vivax DHFR coding sequence was isolated and cloned into the vector pET17 
(Novagen). The resulting plasmid was transformed into E. coli strain HMS174(DE3) 
(Novagen). All 16 possible combinations of mutations at 4 sites (N50I, S58R, S117N, 
I173L) were introduced by QuikChange Site-Directed Mutagenesis Kit (Strategene). 
Each mutageneized plasmid was sequenced to confirm the presence of expected 
mutations, and the absence of any other mutations. Plasmids containing all mutated 
alleles of DHFR were then introduced into E.coli strain LH18, thyA Δfol:kan donated by 
E.E. Howell (Howell, Foster, and Foster 1988). This strain lacks dihydrofolate reductase, 
as well as thymidylate synthase, and requires plating on full LB medium supplemented 
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with 200 mg/mL of thymine for growth. In addition, this strain carries a kanamycin-
resistance selective marker. Once transformed, this strain can be grown on Bonner-Vogel 
minimum medium supplemented with 200 mg/mL of thymine. 
To create yeast strains with the same mutated alleles, we cloned each allele into 
the GR7 shuttle vector, a derivative of the pRS314 yeast shuttle vector (Sikorski and 
Hieter 1989). We used S. cerevisiae strain TH5 (MATa leu2-3,112 trp1 ura3-53, 
dhfr1::URA3 tup1, provided by Carol Sibley) to assay pyrimethamine resistance 
conferred by each DHFR allele. TH5 lacks DFR1, the yeast orthologue of the DHFR 
gene, and when not transformed with functional DHFR, requires media supplemented 
with 100 ul/mL deoxythymidine monophosphate (dTMP, Sigma-Alrich) for growth. TH5 
was transformed with each of the 16 alleles of DHFR on tryptophan drop-out medium 
(SC trp-) to select for the presence of the GR7 vector carrying DHFR. The SC trp- 
medium represents “minimal medium” for yeast strains in all future references. 
We used both yeast and bacterial transgenic systems for our assays to rule out 
possible artifacts of background mutations in the vector to ensure that the results 
represented biologically relevant behavior of the parasite DHFR alleles themselves. In 
this paper, we focus on the results from the yeast transgenic system, but results from both 
systems are strongly correlated. 
 
Growth Rate Calculations 
For each strain, we picked two to five colonies from a solid media plate and 
inoculated the appropriate liquid minimum medium culture with our transformed E.coli 
and yeast strains. After overnight culture, cultures were diluted to an OD600 of 0.01 (or 
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approximately 6 x 104 cells/mL) in a series of concentrations of pyrimethamine in 
minimum medium, and then dispensed into microtiter plates. These plates were 
transferred to a Bioscreen C microbiological workstation (Thermo Labsystems), which 
recorded OD600 readings every 15 minutes for 2 days. Growth rate was calculated by 
taking a least squares linear regression of log absorbance versus time for a 3 hour sliding 
window over the length of the growth curve (Joseph and Hall 2004; Brown et al. 2010). 
Growth rates represent the maximum regression coefficient among all sliding windows.  
 
IC50 Calculations 
We calculated the resistance of each strain using inhibitory concentration 50 
(IC50) measurements, which represent the pyrimethamine concentration at which growth 
rate is 50% of what it is in the absence of pyrimethamine. IC50 values were obtained as 
follows. For each strain, we fit the following logarithmic curve to our growth rate versus 
pyrimethamine concentration: 
 
 
where Gi is the growth rate of strain i, Ai is the maximum growth rate in the absence of 
pyrimethamine, x is the natural log of (pyrimethamine concentration + 1), bi is the 
pyrimethamine concentration at which Gi is half of Ai, and ci is a scaling parameter 
determining the shape of the logistic curve. This curve gave us predicted growth rates at a 
range of pyrimethamine concentrations. Nonlinear least squares regressions were used to 
determine the value of bi, which represents the IC50 values for each strain.  
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Calculation of possible evolutionary trajectories 
To investigate properties of the adaptive landscape, we conducted forward-time 
simulations using simuPOP (Peng and Kimmel 2005). Each simulation began with a 
population of individuals that were fixed for the ancestral haplotype. We drew the 
population size for each simulation from an eunif(ln(1000),ln(100000) distribution, or a natural-log 
scaled uniform distribution from 1,000 to 100,000 individuals. Mutations were then 
added according the relative rate matrix for P. vivax that we computed from the data 
presented in Neafsey et al. (Neafsey et al. 2012). To convert the relative substitution rate 
matrix to more realistic per-generation rate matrix, we divided all relative rates by a 
factor of 103. Ultimately, we are interested in the rate of amino acid substitutions; hence 
to compute the per-generation substitution rates, we summed the rates of all nucleotide 
substitutions that can produce the amino acid substitutions of interest. We performed 500 
simulations at pyrimethamine concentrations 0, 2, 4, 6, 8 corresponding to the 
transformation ln(pyrimethamine concentration + 1). Concentrations above 8 were not 
explored because for most population sizes, substitutions are "nearly neutral", i.e. Ns < 1 
(over the range of population sizes investigated), thus the adaptive landscape is 
effectively flat. Growth rate for each haplotype at each concentration was computed as 
explained above in “Growth Rate Calculations”. We then assigned selective coefficients 
to each haplotype based on the relative maximum growth rates estimated for each 
concentration. Simulations were run until the population fixed the haplotype of optimal 
fitness or until 1,000,000 generations had passed. 
 We used these simulations to determine the adaptive trajectory for each 
simulation as follows. We recorded the frequency of each haplotype every ten 
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generations during the simulation. If, at one time step, any haplotype had a frequency 
greater than 0.5, we considered the population to be in this state. We then recorded the 
transitions between haplotypes and removed loops (e.g. a transition from haplotype 3 to 4 
and immediately back again to 3 is recorded as just 3) to determine the adaptive 
trajectory for that simulation. These were then compiled for each concentration and the 
four most likely adaptive trajectories determined from the aggregate. 
 
RESULTS 
 
In order to assess how various mutational combinations in the coding sequence of 
P. vivax DHFR affected resistance to pyrimethamine, a drug which competitively inhibits 
this protein’s activity, we created all 16 possible combinations of the mutants N50I, 
S58R, S117N, and I173L. The mutagenized DHFR coding sequences were cloned into a 
yeast vector and transformed into a yeast strain lacking DFR1, the yeast orthologue of the 
DHFR gene. 
 We estimated the level of pyrimethamine resistance as the concentration of drug 
that inhibited cell growth by half, a metric known as the IC50 (see Methods). The results 
are shown in the barplot in Figure 3. 1. The DHFR alleles indicated along the horizontal 
axis are given in the form of a vector of 0’s and 1’s corresponding, from left to right, the 
amino acid residues 50, 58, 117, and 173. Each 0 indicates a nonmutant codon, and each 
1 indicates a mutant codon. Therefore 0000 indicates the wildtype, nonmutated allele, 
and 1111 indicates the quadruple mutant. Figure 3. 1 shows that of the four single 
mutants, 0010 is much more resistant to pyrimethamine, and may likely be favored as the 
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first mutational step. Consistent with data from previous yeast or bacterial 
complementation systems for P. falciparum DHFR (Lozovsky et al. 2009; Brown et al. 
2010), the quadruple mutant (N50I, S58R, S117N, I173L) was the most resistant, with 
triple mutants also exhibiting high levels of resistance. Clinical data from malarial 
patients treated with a sulfadoxine-pyrimethamine drug regimen showed higher failure 
rates with P. vivax DHFR quadruple mutants compared to wildtype (Tjitra et al. 2002).  
Figure 3. 2 shows estimated growth rates of all alleles across a range of drug 
concentrations. Alleles vary not only at the point at which they cross the Y-axis (growth 
in the absence of pyrimethamine), or concentration of drug at which growth is reduced by 
half (IC50), but also by the shape of the logistic growth curve (whether growth falls 
sharply with increasing dosage of drug). Beyond the obvious low resistance of the 
wildtype 0000 allele and the very high resistance of the quadruple mutant 1111 allele, the 
evolutionary landscape is complex. Epistatic interactions among the mutant sites are 
common (Table 3.1). For example, the S58R mutation increases resistance in 4 
backgrounds, has a negligible effect on resistance in 3 backgrounds, and actually 
decreases resistance in 1 allelic background. 
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Figure 3.1. Boxplot showing resistance phenotypes of 16 DHFR alleles mutated at four 
possible sites. Alleles are shown in order of increasing resistance. 
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Figure 3.2. Fitted logarithmic growth rates of all alleles at increasing concentration of 
pyrimethamine. Concentration of pyrimethamine (x) is transformed as ln(x+1). Black line 
represents wildtype (0000) allele, which is least resistance to pyrimethamine. Single 
mutants (1000, 0100, 0010, 0001) are represented by blue lines. Double (0011, 0101, etc) 
and triple mutants (1110, 1011, etc) are represented by green and orange lines, 
respectively. Red line quadruple mutant (1111) is the most resistant allele. 
 
 
 
 92 
Table 3.1. Summary of mutational effects on pyrimethamine resistance in DHFR. 
*Differences in mean IC50 values are significant at P < 0.05, after Bonferroni correction. 
Mean proportional increase of IC50, geometric mean across all 8 alleles. 
DHFR alleles on which mean mutational effect is  
 
Mutation 
Positive* Negative* Negligible 
Mean fold 
proportional 
increase 
N50I 3 0 5 3.85 
S58R 4 1 3 2.25 
S117N 8 0 0 29.9 
I173L 2 1 5 1.63 
 
 
 
 Correlation between IC50 values for P. vivax and P. falciparum dhfr alleles were 
strongly significant and positive (rho = 0.8607, P = 2.2e-16, Spearman rank correlation 
test, P. falciparum DHFR data from (Lozovsky et al. 2009), Supplementary Figure S3.1). 
Allele 0011 was removed from this calculation because this allele failed to grow in P. 
falciparum DHFR, most likely due to adaptive conflict between resistance to inhibition 
and maintenance of enzyme activity. In contrast, the P. vivax 0011 DHFR allele 
maintained functional enzyme activity, and had high resistance to pyrimethamine. 
The development of a new function often comes at a cost of a previous function, 
thus proteins evolving for increased drug resistance are often thought to be under 
adaptive conflict for endogenous function. In our case, the evolution of resistance to 
pyrimethamine may compromise the catalytic activity of DHFR. However, this kind of 
trade-off may not be necessary, as was suggested by Brown et al, (Brown et al. 2010), 
who observed no association between resistance level and growth rate. In our data, we 
also see no clear association between these two phenotypes, as correlation analysis 
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reveals (Pearson’s correlation between log-transformed IC50 and maximum growth rate 
in the absence of drug, P = 0.3416). However, maximum growth rate in the absence of 
drug and IC50 are only two metrics, which taken individually paint an incomplete picture 
of fitness. As Figure 3.2 shows, drug concentration has a strong effect on relative fitness 
of alleles, with landscapes dominated by the wildtype (0000) allele in the absence of drug 
(pyrimethamine concentration equal to 0) and very flat at high drug concentrations. The 
flat fitness landscape at high drug concentrations means there are no pronounced peaks or 
valleys, and the population is fixing alleles mainly by drift. Simulations for evolutionary 
pathways in such landscapes can give us little insight into the likely evolutionary 
pathway of new mutations, and were excluded from analysis. Gene-by-environment 
interactions are important, as moderate dosages of pyrimethamine have greater power to 
select for resistant alleles. This is because, in contrast to the flat landscapes at either 
dosage extreme, moderate dosages induce greater variation in fitness differences between 
the alleles. In addition, effective population size of the malaria species and mutation bias 
in the genome can also affect the path of evolution. In order to simulate an evolutionary 
pathway for DHFR evolution, we incorporated all these elements in a forward time 
simulation (see Methods).  
 The results of the simulation are displayed in Figure 3.3. In the absence of drug, 
the fitness landscape is dominated by the fitness peak of the wildtype (0000) allele.  
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Figure 3.3. Proportion of simulation runs which fixed for any particular allele, at varying 
concentrations of pyrimethamine. Concentration of pyrimethamine (x) is transformed as 
ln(x+1). “Other” represents alleles which fixed, but with frequencies of less than 1%. 
“Polymorphic” represents simulations which remained segregating for polymorphic 
alleles at the end of 1 million generations. 
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Despite random mutations and sometimes small population sizes, no simulations ever 
wandered off this peak. At higher drug concentrations (log transformed pyrimethamine 
concentrations 2 to 6), the quadruple mutant does not have the highest fitness (Figure 3. 
2), likely reflecting adaptive conflict between resistance and catalytic activity. The triple 
mutant 1110 allele fixes in the vast majority of cases, and populations that remain 
segregating for two or more polymorphic alleles at the end of 1 million generations make 
up a small percentage of the runs (2.4%, 1.0%, and 0% for log transformed 
concentrations 2, 4, and 6 respectively). At a log transformed pyrimethamine 
concentration of 8, which translates into an actual pyrimethamine concentration of ~3000 
uM, the quadruple mutant 1111 allele fixes in 99.8% of simulated runs. At this 
concentration, the 1111 allele resides at the highest peak of the fitness landscape. Again, 
since we use growth rates to estimate fitness at different drug dosages, this fitness is 
informed by both resistance and catalytic activity. Taken together, these results suggest 
that despite being the most resistant allele, the quadruple mutant is not selectively favored 
unless very high dosages of drugs are administered. These simulations also reinforce the 
idea that effective population size plays a large role in the time to fixation of favorable 
alleles, with larger population sizes leading to faster fixation of favorable mutations 
(Figure S3.2). In addition, smaller effective population sizes were more likely to fix 
alleles which were not the absolute fitness peak in the landscape, because drift pushed 
them more frequently onto sub-optimal peaks (Table S3.1). 
This result is consistent with amino acid replacements observed in worldwide 
surveys of P. vivax (Table 3.2). The majority of P. vivax samples isolated from patients in 
Southeast Asia and India were mutated in at least one of these four positions. In contrast  
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Table 3.2. Worldwide prevalence of polymorphic P. vivax DHFR alleles containing 
mutations N50I, S58R, S117N, and/or I173L. References in Table S3.3. 
Allele Location 
S58R/S117N (0110) Thailand, Myanmar, Cambodia, Myanmar, China, 
India, Mauritania, Iran, Pakistan, French Guiana, 
Ethiopia, Madagascar 
S58R/S117N/I173L (0111) French Guiana, Myanmar  
S58R (0100) Thailand, India, Indonesia, Vietnam, Vanuatu, China, 
East Timor 
N50I/S58R/S117N/I173L (1111) Not found 
 
 
 
to the prevalence of the 1111 allele in P. falciparum samples (van den Broek et al. 2004; 
Anderson et al. 2005; Ahmed et al. 2006), this allele has not yet been observed in P. 
vivax, perhaps because clinical dosages of pyrimethamine never reach high enough levels 
for the quadruple mutant to have a fitness advantage. Another possibility is that long-term 
maintenance of the quadruple allele requires the presence of a compensatory mutation 
elsewhere in the genetic background, as has been shown in P. falciparum (Nair et al. 
2008). 
Other polymorphisms commonly found in natural isolates (such as the alleles 
0110 and 0111) do coincide with several of the intermediates predicted by our simulated 
most likely pathways (Figure 3.4). Two things are notable from these results. First, 
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despite the striking similarity between IC50 of alleles between P. falciparum and P. 
vivax, the trajectories differ. For example, at the highest pyrimethamine concentration we 
examined, where the quadruple mutant fixed in most simulations, the first evolutionary 
step was most often 0100 in our simulations (Figure 3.4D), but 0010 in P. falciparum 
(Lozovsky et al. 2009). However, at lower pyrimethamine concentrations, 0010 was also 
the first evolutionary step in P. vivax. This highlights the subtle differences in fitness 
landscapes produced by using IC50 alone (as in the case of P. falciparum simulations) 
and by using a multi-parameter model incorporating drug concentration, selection, and 
drift, as we did with P. vivax. The second notable point is that the allele 1110, which is an 
important intermediate step in our evolutionary pathways, has not yet been isolated in 
natural populations. The overall increased nucleotide diversity in P. vivax compared to P. 
falciparum is reflected in the variation found in P. vivax DHFR alleles, where mutations 
other than the ones studied here are sometimes found at high frequencies.  Epistatic 
interactions between these multitudes of mutations could result in evolutionary pathways 
that were unexplored in our simulations. For example, the 1110 background may stand as 
an unfavorable background for an otherwise highly favored mutation. Such sign epistasis 
is quite common, both within genes, as demonstrated by amino acid replacement S58R 
and I173L in our results (Table 3.2) and in β-lactamase in E.coli (Weinreich et al. 2006); 
as well as between genes, such as in Methylobacterium (Chou et al. 2011).  
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Figure 3.4. Preferred evolutionary pathways of pyrimethamine resistance in P. vivax 
DHFR. Panels A, B, C, and D represent log transformed pyrimethamine concentrations of 
x = 2, 4, 6, 8, respectively, where the transformation is evaluated at ln(x+1). The top four 
major pathways for each concentration are shown, except when probabilities fall below 
0.01. Widths of lines in pathways correspond to their probabilities. The major pathway is 
shown in red, and given with an estimated probability.  
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DISCUSSION 
 
 We describe the resistance of mutant DHFR proteins in P. vivax to the anti-
malarial drug pyrimethamine. Correlation analysis reveals that the adaptive landscape of 
the P. vivax DHFR alleles is highly correlated with the adaptive landscape of the P. 
falciparum DHFR alleles (Lozovsky et al. 2009). This suggests that orthologous 
mutations in the active sites of related proteins have similar functional significance for 
relatively distantly related species. This hypothesis is supported by more recent 
computational analysis of binding between malaria DHFR and anti-folates in four 
Plasmodium species – P. falciparum, P. vivax, P. malariae, and P. ovale – which found 
binding to be broadly similar, and determined by an analogous set of seven residues 
(Choowongkomon et al. 2010). In a way, this result is surprising, since P. vivax 
nucleotide diversity far surpasses that of P. falciparum nucleotide diversity, and 
mutations which are rare or missing in P. falciparum have been found to be important for 
resistance in P. vivax (Hawkins et al. 2007). Thus, we would not necessarily expect 
analogous mutations to have similar functional consequences. However, this result is also 
intuitively congruent with our current understanding of function in orthologous proteins 
that share common active sites. 
The evolutionary pathways we identified to be important in the evolution of 
DHFR in P. vivax have been previously identified by in vivo studies of therapeutic 
efficacies of ACT-pyrimethamine combination drugs: natural isolates from Indonesia 
found mutations at residues 58 and 117 common in P. vivax isolates of malaria patients, 
as well as quadruple mutations (at residues 57, 58, 61, 117) (Tjitra et al. 2002). These 
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mutations were associated with increased resistance to sulfadoxine-pyrimethamine 
treatments. Based on these results, the authors suggested stepwise drug selection process 
in mutations favored mutation at residue 117 first, followed by mutations at 50, 58, which 
aligns with our results. Additional mutations favored by natural selection, but which were 
not assessed by us, included mutations at residues 57 and 61. 
The serine to asparagine mutation in codon 117 (which corresponds to position 
108 in P. falciparum) has repeatedly been demonstrated to be a major determinant of 
antifolate resistance (de Pécoulas et al. 1998; Sibley et al. 2001; Tjitra et al. 2002). The 
importance of the S117N mutation for resistance in P. vivax is even more stark than the 
S108N mutation in P. falciparum: in P. vivax, the S117N mutation confers a ~4000 fold 
increased resistance to pyrimethamine (Leartsakulpanich et al. 2002), whereas in P. 
falciparum, the S108N mutation confers only a ~100 fold increased resistance (Cowman 
et al. 1988; Peterson, Walliker, and Wellems 1988). Analysis of crystal structures of the 
DHFR protein reveals that a steric conflict arising from the side chain of a S117N mutant 
enzyme, accompanied by loss of binding to the serine at residue 120 is mainly 
responsible for the reduction in binding of pyrimethamine (Kongsaeree et al. 2005). 
In addition to amino acid replacement S117N, in vitro assays of pyrimethamine 
sensitivity in mutated P. vivax isolates also identified S58R to be important for resistance 
(de Pécoulas et al. 1998). The importance of these mutations for resistance in 
Plasmodium DHFR has also been observed in P. malariae, where natural isolates 
resistant to pyrimethamine contained mutations S58R and S114N, corresponding to S58R 
and I173L in P. vivax and C59R and S108N in P. falciparum (Khim et al. 2012).  
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Some additional mutations which are associated with pyrimethamine resistance in 
P. vivax include F57L and T61M. Two amino acid replacements which have been found 
to be important for evolution of resistance in P. falciparum DHFR (N51I and I164L), are 
analogous to mutations N50I and I173L in P. vivax, but were very rarely observed in 
natural isolates in the latter species. 
Pyrimethamine binds directly to the active site of DHFR, and competitively 
prevents the binding of dihydrofolates (Yuvaniyama et al. 2003). DHFR evolves 
resistance to pyrimethamine through acquiring substrate specificity for dihydrofolate 
(Rastelli et al. 2000). Such modifications to the active site of an enzyme is thought to 
impose greater trade-offs in native enzyme function than drugs that bind externally 
(Berkhout 1999; Tawfik 2005). Kinetic parameters of protein function are the 
pyrimethamine dissociation constant (Ki) and the catalytic turnover rate (kcat). The relative 
fitness of parasites is highly informed by these two parameters, the first of which 
indicates level of resistance while the second indicates maintenance of endogenous 
function. In the case of malaria DHFR, adaptive conflict is in play as improved substrate 
specificity (Ki) often comes at the expense of catalytic activity (kcat) (Sirawaraporn et al. 
1997; Lozovsky et al. 2009) In other cases, the trade offs may be absent, as (Brown et al. 
2010) showed that DHFR proteins are capable of evolving resistance without 
compromising existing function.  We directly analyzed how adaptive conflict can shape 
evolution at various drug concentrations by using relative growth rates (which 
incorporate both substrate specificity and catalytic capacity) into our simulations of 
evolutionary pathways across fitness landscapes.  
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 Our simulations showed that fitness landscapes could vary dramatically across 
drug concentrations. The wildtype allele (0000) shows the highest fitness in a drug-free 
environment, supporting the adaptive conflict theory that trade-offs can occur between 
resistance and growth. Although the quadruple mutant (1111) has the highest IC50 value, 
it is not the most favored allele at most drug concentrations. In fact, at lower drug 
concentrations, endogenous enzyme activity is compromised to an extent that limits the 
fitness benefits derived from higher drug resistance. A small window of drug 
concentrations can favor the fixation of the quadruple mutant, which in our assays was 
around 3000 uM pyrimethamine. However, it is difficult to predict how this concentration 
translates into an analogous dosage in a human patient, outside of a yeast transgenic 
system. Nevertheless, the incorporation of drug concentrations as a factor for predicted 
evolutionary pathways is a novel approach in tracking drug resistance in malaria 
research. This has important ramifications for human health. Since fitness landscapes are 
so strongly shaped by drug dosages, clinicians could modify dosage procedures over the 
course of treatment to subvert the evolution of resistance. This could be done perhaps by 
drawing populations into repeated cycles of suboptimal fitness using varying 
concentrations of drug, which induce previously highly fit alleles to reside at suboptimal 
fitness peaks in the current dosage regime. 
 Mathematical modeling based on another anti-malarial drug, mefloquine, suggest 
that drug dosage plays a strong role in selection of resistance (Simpson et al. 2000). They 
suggest that the initial deployment of lower doses provides an opportunity for selection of 
resistant alleles. This resistance would spread more rapidly than the de novo application 
of maximal doses. Our simulations show that maximal doses that do not allow the growth 
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of any alleles can circumvent resistance (in our yeast vector system, this does was ~3000 
uM), however such high doses are probably eschewed as clinical treatments because of 
intolerable toxic side effects. Lower dosages of drugs can achieve adequate levels of 
parasetemia clearance with unmutated alleles, but also provides a breeding ground for 
resistance. 
Ranked IC50 values for S. cerevisiae and E. coli strains carrying the same DHFR 
alleles are significantly correlated (rho = 0.7323, P-value =  0.001812, Table S3.2). The 
similarity of resistance phenotypes in two different species rules out experimental 
artifacts such as mutations in the genetic background of the yeast strains. Despite these 
similarities, the yeast and bacterial systems differ in some notable respects. For example, 
in yeast, a higher concentration of pyrimethamine is needed to inhibit DHFR activity 
sufficiently to measure IC50 than in bacterial cells: mean ln(IC50+1) values for E.coli is 
3.58, versus 5.40 for S. cerevisiae. This may reflect a lower requirement for DHFR 
activity in yeast relative to E. coli, as has been previously noted (Brown et al. 2010).  
An in-depth understanding of the molecular pathways of resistance evolution is 
necessary because infections by P. vivax pose a serious challenge to global health in Asia, 
South America, Central America, the Middle East, and parts of Africa (Hawkins et al. 
2007; Parekh and Moorthy 2011). Our results lend novel insights into the evolution of 
anti-malarial resistant in the DHFR protein of P. vivax. The larger than expected 
agreement between major pathways identified in our analysis, and those observed in 
natural populations of P. vivax (Table 3.1), supports the use of model organisms in 
studies of drug resistance, particularly in organisms, such as P. vivax, that do not lend 
themselves to easy continuous culture in the laboratory. However, differences between 
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the laboratory setting and the field are manifold, and may explain why the most resistant 
quadruple mutant has not yet been found in nature. For example, we can create artificially 
high drug dosages in the laboratory that are avoided in the clinic, leading us to over-
estimate the fitness of very resistant alleles, which likely evolve in a naturally lower drug 
dosage environment where their fitness advantage is reduced by negative trade-offs over 
endogenous function. Nonetheless, two results strengthen the validity of using model 
systems to predict evolutionary examples. The first is the congruence of growth rates for 
P. vivax alleles expressed in the E. coli and S. cerevisiae systems, which seems to rule out 
experimental artifacts. And the second is the extreme correlation between the fitness of 
corresponding alleles in P. vivax and P. falciparum. Both these observations strongly 
support the use of model organisms as a helpful system for studying the evolution of the 
malaria parasite. 
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SUPPLEMENTARY MATERIAL 
 
 
 
 
Figure S1.1 –  A) Crossing scheme for substituting Y chromosomes from one population 
into the genetic background of the other. Drosophila males lack meiotic recombination, 
therefore no balancer chromosomes were necessary. Only crosses resulting in YF in an 
Indian genetic background are shown, but crosses resulting in YI in a French genetic 
background are analogous. B) Crossing scheme for introgressing Y chromosomes into a 
common laboratory stock genetic background.  
A. 
B. 
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Figure S1.2 –  Crosses to observe effects of Y chromosome and genetic background on position 
effect variegation. Bloomington Stock B6175 (In(1)w[m4h]; Su(var)3-10[2]/TM3, Sb[1] Ser[1]) 
females were used. Females have X chromosomes with an inversion placing w[m4h] close to the 
centromere. The second chromosome is heterozygous for a Sb/Ser dominant marker, selection of 
which removes the dominant Su(var) (Suppressor of variegation) and allows variegation of 
w[m4h]. 
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Table S1.1 –  Number of genes identified by Maanova to be significantly modulated by 
Y-by-background effects (FDR < 0.01) which were also identified by BAGEL (P > 0.95) 
as differentially modulated by the Y chromosome in one, two, or all three of the genetic 
backgrounds examined (Indian, French, or B4361). The number of genes uniquely 
identified as displaying Y-by-background effects but not in the analysis with BAGEL are 
also shown.  
 Number of genes overlapping with BAGEL (%) 
Maanova  No overlap 1 background 2 backgrounds 3 backgrounds 
Y-by-background 
effects (346 genes 
in total 
94 (27%) 169 (49%) 76 (22%)  7 (2%) 
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SUPPLEMENTARY MATERIALS 
 
 
 
 
 
Figure S2.1. Crossing scheme for substituting creating males with A) normal sex 
chromosome inheritance (X-maternal, Y-paternal), or B) males with reverse sex 
chromosome inheritance (X-paternal, Y-maternal). Line 1: Attached X females were 
collected from Bloomington Stock 995, C(1;Y)3, ln(1)FM7, w[1] m[2]/0/C(1)M4, y[2]. 
Males carrying balancers on the 2nd and 3rd chromosomes were collected from 
Bloomington Stock 7199, w[*]; Kr[IF-1]/CyO; D[1]/TM6C, Sb[1] Tb[1]. Line 2 and 3: 
Yi males were collected from Y-substitution lines carrying Y-Cs or Y-Con. Crosses for 
these Y-substitution lines were carried out as previously described (LEMOS et al. 2008). 
Crosses were done independently for each Y chromosome lineage such that males have 
different Y chromosomes introgressed into a common isogenic background, with 
recessive markers (r) on each chromosome (these markers are y; bw; e; ci ey on the X, 
1st, 2nd, 3rd, and 4th chromosomes, respectively).  
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A.  
 
B.  
 
 
Figure S2.1. (Continued).
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Figure S2.2. Experimental design of hybridization scheme for microarrays to collect 
genome-wide gene expression data.  Each arrow denotes one hybridization reaction, with 
Cy3 labeling at the foot, and Cy5 labeling at the head, of the arrow. 
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Figure S2.3. Crosses to observe effects of reverse sex chromosome inheritance on 
position effect variegation (PEV). Bloomington Stock B6175 (In(1)w[m4h]; Su(var)3-
10[2]/TM3, Sb[1] Ser[1]) females were used. Males and females have X* chromosomes 
with an inversion placing w[m4h] close to the centromere. The second chromosome is 
heterozygous for a Sb/Ser dominant marker, selection of which removes the dominant 
Su(var) (Suppressor of variegation) and allows variegation of w[m4h]. A) Deriving 
males with normal sex chromosome inheritance, and variegating expression of w[m4h]. 
B) Deriving males with reversed sex chromosome inheritance, and variegating expression 
of w[m4h]. 
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A.  
 
B.  
 
Figure S2.3. (Continued).
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Figure S2.4. Crosses used to generate individuals with reversed sex chromosome parent-
of-origin inheritance. In both crosses, maternal genotype was XXY. * indicates the wm4h 
gene, which was used for PEV assays (see Methods). 
 
XY males with X^X/Y mothers or X^Y/X mothers
X *
X *
*Xpat
Ymat
X **
*
X
*
*Xmat
Ypat
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A. 
 
B. 
 
Figure S2.5. PEV differences between males inheriting sex chromosomes as A) normal 
(Xmat, Ypat), as illustrated in Figure S2.4 right panel, or B) males inheriting reversed 
parent-of-origin sex chromosomes (Xpat, Ymat), as illustrated in Figure S2.4 left panel. 
In each case, males had aneuploid XXY mothers.  
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Figure S3.1. Correlations between ranked resistance phenotypes (1 is lowest resistance, 
16 is highest resistance) of P. vivax and P. falciparum DHFR alleles. Allelle 0011 was 
omitted because this allele in P. falciparum DHFR failed to grow. 
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Figure S3.2. At low concentrations of pyrimethamine, effective population size (Ne) has 
no effect on time to fixation of an allele since almost all simulations never moved off of 
the fitness maximum of the wildtype 0000 allele. At higher concentrations of 
pyrimethamine, Ne has a strong effect on the number of generations required for any 
particular allele to fix. As expected from population genetics theory, larger Ne increases 
the efficacy of selection, and reduces the number of generations required for fixation.  
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Figure S3.2. (Continued).
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Table S3.1: Mean effective population size of simulations which fixed for the highest 
fitness allele (0000, 1110, 1110, 1110, and 1111 for ln(pyrimethamine+1) concentrations 
of 0, 2, 4, 6, and 8, respectively), and for all other alleles.  
 
 Highest fitness allele All other alleles 
0 21961 N/A 
2 26523 6894 
4 24258 2220 
6 18737 9576 
8 23770 1214 
 
 123 
 
Table S3.2. Comparison of ln(IC50+1) and ranked IC50 values between S. cerevisiae and 
E. coli strains carrying the same DHFR alleles. Ranked alleles are indexed from 1 (least 
resistant) to 16 (most resistant). 
Allele S.c. ln(IC50+1) S.c. ranked IC50 E.c. ln(IC50+1) E.c. ranked IC50 
0000 0.8104 1 0.3752 1 
0001 1.5305 2 2.2106 7 
0010 6.5701 10 5.4461 12 
0011 7.0782 12 6.4972 15 
0100 3.1450 3 0.3791 3 
0101 4.6556 6 1.3804 5 
0110 6.6353 11 4.2190 8 
0111 7.4138 14 6.1458 14 
1000 4.7019 7 0.3808 4 
1001 5.7108 8 5.4480 11 
1010 7.2145 13 4.9754 10 
1011 6.3726 9 7.2890 16 
1100 4.6333 5 0.3775 2 
1101 4.4496 4 1.8584 6 
1110 7.5496 15 4.8127 9 
1111 7.9816 16 5.4790 13 
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Table S3.3. Works cited for polymorphic DHFR alleles in P. vivax 
Allele Location 
S58R/S117N (0110) Thailand (1), Myanmar (1), Cambodia (1), China (2), 
India (3), Mauritania (4), Iran (5), Pakistan (6), 
French Guiana (7), Myanmar (8), Ethiopia (9), 
Madagascar (10) 
S58R/S117N/I173L (0111) French Guiana (1, 7), Myanmar (11)  
S58R (0100) Thailand (1), India (12), Indonesia (13), Vietnam(14), 
Vanuatu (14), China (14), East Timor (14) 
N50I/S58R/S117N/I173L (1111) Not found 
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